Document:

Exhibit
10.19

 

LOAN
AGREEMENT

 

This
Loan Agreement (“Agreement”) is made and entered into in this 24th day of March, 2020 (“Effective Date”),
by and between Todos Medical Ltd., an Israel corporation, its successors and assigns (the “Company”), and Ethel Zelniec
(“Lender”).

 

RECITALS

 

WHEREAS,
the Company is in need of capital for working capital and inventory and Lender has agreed to provide up to $100,000.00 of such
capital according to the terms hereof; and

 

WHEREAS,
Lender and Company enter into this Agreement to establish terms by which Lender, in its sole discretion, may fund Loans, as set
forth herein and therein the related Note, described below.

 

AGREEMENT

 

NOW,
THEREFORE, in consideration of the mutual covenants and agreements contained herein, and other good and valuable consideration,
the sufficiency of which is acknowledged by Lender and Company (each “party” and, collectively, “parties”),
the parties hereby agree as follows:

 

1.
LOANS; PROMISSORY NOTES. Lender may loan the Company up to $100,000.00 pursuant to the terms hereof; provided, nothing
herein or otherwise shall obligate Lender to make any Loan to the Company. All sums advanced pursuant to the terms of this Agreement
(each a “Loan” and collectively, the “Loans”) shall be evidenced by an interest rate of 10% convertible
promissory note (each a “Note” and collectively, the “Notes”), in substantially the form set forth as
Exhibit A hereto. Each Note shall be in the aggregate principal amount of the Loan made at each Closing (as defined below) and
shall be convertible into shares of the Company’s common stock (the “Common Stock”) pursuant to the terms contained
in each Note at the earlier of registration or six (6) months from each Closing. All covenants, conditions and agreements contained
herein are made a part of each Note, unless modified therein.

 

a.
The Company agrees to designate the Notes as senior to any existing and future indebtedness and secured by all assets of the Company.

 

b.
It is currently anticipated that Loans shall be made according to the schedule contained in Exhibit C hereto.

 

c.
Any request for a Loan may be made from time to time and subject to Lender approval. Requests for Loans may be made orally or
in writing. Lender may refuse to make any requested Loan in its sole discretion.

 

e.
Unless stated otherwise in the Note, the Note will automatically mature three (3) months from the date of the applicable Note.

 

f.
All sums advanced pursuant to this Agreement shall bear simple interest from the date the Loan is made until paid in full at an
interest rate of ten percent (10%) per annum. Interest not paid shall not compound and will be calculated on the basis of a 360-day
year. Interest shall be paid by the Company quarterly.

 

2.
WARRANTS. Upon the sale of the Notes by the Company to the Lender, the Company may issue up to 4,464,281 warrants to
the Lender in substantially the form annexed hereto as Exhibit B (the “Warrant”) at an exercise price of $0.10 per
share (the “Warrant Shares”). The Warrant shall be cashless exercisable with full ratchet anti-dilution, for a period
of five (5) years from the issue date specified on the face of such Warrant.

 

    	Page | 1
	 	 

    	Loan Agreement	 	 

    

 

3.
CLOSING. The closing for the Note (the “Closing”) shall take place on or about March 24, 2020, provided
that the Company has delivered the executed Transaction Documents (as defined below) to the Lender (“Closing Date”).

 

4.
REGISTRATION RIGHTS. The Company shall prepare and file with the United States Securities and Exchange Commission (the
“Commission”) a registration statement on Form F-1 (the “Form F-1” or “Registration Statement”)
by the earlier of (i) 75 days of the Effective Date or (ii) 30 days after uplisting of the Company’s Common Stock to a national
securities exchange to cover two times the Common Stock underlying the Note conversion based on the lower of (i) the closing market
price on the date of Closing and (ii) 50% of the lowest trading price on the primary trading market on which the Company’s
Common Stock is quoted for the last ten (10) trading days immediately prior to but not including the Conversion Date, and the
Warrant Shares. The Form F-1 must be effective within 180 days from the Effective Date of this Agreement. There shall be monthly
liquidated damages of $12,500 if the Registration Statement is not filed by the earlier of (i) 75 days of the Effective Date or
(ii) 30 days after uplisting of the Company’s Common Stock to a national securities exchange and/ or declared effective
within 180 days from the Effective Date of this Agreement, which damages shall accrue each month until the applicable breach (failure
to timely file, failure to timely have declared effective, or both) has been cured. The parties acknowledge and agree that damages
which will result to Lender for Company’s failure to timely file or have declared effective the Registration Statement shall
be extremely difficult or impossible to establish or prove, and agree that the payment of $12,500 per month is a reasonable estimate
of potential damages and shall constitute liquidated damages for any breach of this paragraph. Any amounts due under this Section
shall be paid by the fifth (5th) day of the month following the month in which they accrued or, at the option of Lender, added
to the principal of the Note. The legal fees associated with filing the Form F-1 shall be paid by Company.

 

5.
REPRESENTATIONS AND WARRANTIES BY THE COMPANY. In order to induce Lender to enter into this Agreement and to make the
Loans provided for herein, Company represents and warrants to Lender as follows:

 

a.
Organization, Good Standing and Power. The Company is a corporation duly incorporated, validly existing and in good standing
under the laws of Israel and has the requisite corporate power to own, lease and operate its properties and assets and to conduct
its business as it is now being conducted.

 

b.
Non-Shell Status. The Company is not now or ever been a shell as that term is defined in Rule 405 of the Securities Act.

 

c.
Authorization; Enforcement. The Company has the requisite corporate power and authority to enter into and perform this
Agreement, the Note, and the Warrants (all such documents together with all amendments, schedules, exhibits, annexes, supplements
and related items, to each such document shall hereinafter be collectively referred to as, the “Transaction Documents”).
The execution, delivery and performance of the Transaction Documents by the Company, and the consummation by it of the transactions
contemplated in, have been duly and validly authorized by all necessary corporate action. The Transaction Documents, when executed
and delivered, will constitute valid and binding obligations of the Company enforceable against the Company in accordance with
their terms, except as such enforceability may be limited by applicable bankruptcy, insolvency, reorganization,
moratorium, liquidation, conservatorship, receivership or similar laws relating to, or affecting generally the enforcement of,
creditor’s rights and remedies or by other equitable principles of general application.

 

    	Page | 2
	 	 

    	Loan Agreement	 	 

    

 

d.
Disclosure. None of the Transaction Documents nor any other document, certificate or instrument furnished to the Lender
by or on behalf of the Company in connection with the transactions contemplated by the Transaction Documents contains any untrue
statement of a material fact or omits to state a material fact necessary in order to make the statements made herein or therein,
in the light of the circumstances under which they were made herein or therein, not misleading.

 

e.
Adequate Shares. The Company will at all times have authorized and reserved a sufficient number of shares of Common Stock
to provide for the exercise of the rights represented by the respective Warrants and Note.

 

f.
Periodic Filings. The Company at all times will remain current in its reporting requirements with the SEC under the Securities
Exchange Act of 1934, as amended (the “Exchange Act”) including maintaining XBRL financial information on the Company’s
corporate website.

 

g.
Additional Issuances. Except for the transactions contemplated by the Transaction Documents, the Company, for a period
of twelve (12) months from the date hereof, will not issue, grant or sell any security with a variable conversion or exercise
rate.

 

6.
REPRESENTATIONS AND WARRANTIES BY LENDER. Lender, by its acceptance of this Note, represents and warrants to Company
as follows:

 

(a)
Lender is acquiring the Note with the intent to hold as an investment and not with a view of distribution.

 

(b)
Lender is an “accredited investor” within the definition contained in Rule 501(a) under the Securities Act of 1933,
as amended (the “Securities Act”), and is acquiring the Note for its own account, for investment, and not with
a view to, or for sale in connection with, the distribution thereof or of any interest therein. Lender has adequate net worth
and means of providing for its current needs and contingencies and is able to sustain a complete loss of the investment in the
Note, and has no need for liquidity in such investment. Lender, itself or through its officers, employees or agents, has sufficient
knowledge and experience in financial and business matters to be capable of evaluating the merits and risks of an investment such
as an investment in the Securities, and Lender, either alone or through its officers, employees or agents, has evaluated the merits
and risks of the investment in the Note.

 

(c)
Lender acknowledges and agrees that it is purchasing the Note hereunder based upon its own inspection, examination and determination
with respect thereto as to all matters, and without reliance upon any express or implied representations or warranties of any
nature, whether in writing, orally or otherwise, made by or on behalf of or imputed to the Company.

 

(d)
Lender has no contract, arrangement or understanding with any broker, finder, investment bank, financial intermediary or similar
agent with respect to any of the transactions contemplated by this Agreement.

 

(e)
No Shorting, Etc. Lender agrees that for a period of twenty-four (24) months after the Closing of the sale by the Company to Lender
of a Note, neither Lender nor any of its affiliates, whether in their own capacity or through a third party, shall directly or
indirectly enter into or effect any “short sales” (as such term is defined in Rule 10a-1 of the Exchange Act) of shares
of Common Stock or any hedging transaction, including obtaining and/or borrowing any shares of Common Stock, which establishes
a net short position with respect to the shares of Common Stock underlying the Warrants and Note, whether on a U.S. domestic exchange
or any foreign exchange.

 

    	Page | 3
	 	 

    	Loan Agreement	 	 

    

 

7.
LIQUIDATED DAMAGES.

 

a.
If (i) the Registration Statement on Form F-1 is not filed with the SEC on or prior to the date 30 days from the Effective Date,
(ii) the Registration Statement has not been declared effective by the SEC on or prior to the date 105 days from the Effective
Date, or (iii) any registration statement required by this Agreement is filed and declared effective by the Commission but shall
thereafter cease to be effective or fail to be usable for its intended purpose (each such event referred to as a “Registration
Default”), the Company hereby agrees to pay liquidated damages (“Liquidated Damages”) to Lender $12,500 per
month until the Form F-1 takes effective. Following the cure of all Registration Defaults relating to any particular registrable
Securities, Liquidated Damages shall cease to accrue; provided, however, that, if after Liquidated Damages have ceased to accrue,
a different Registration Default occurs, Liquidated Damages shall again accrue pursuant to the foregoing provisions. Any amounts
due under this Section shall be paid by the fifth (5th) day of the month following the month in which they accrued.

 

b.
If the Company fails to deliver any Securities due Lender hereunder on the date dictated by this Agreement (each a, “Delivery
Date”), the Company shall pay to Lender in immediately available funds $1,000.00 per day past the Delivery Date that the
Securities are actually issued. Any amounts due under this Section shall be paid by the fifth (5th) day of the month
following the month in which they accrued. The Company agrees that the right to receive Securities is a valuable right to Lender
and a material consideration of it entering this Agreement. The parties agree that it would be impracticable and extremely difficult
to ascertain the amount of actual damages caused by a failure of the Company to timely deliver shares as required hereby. Therefore,
the parties agree that the foregoing liquidated damages provision represents reasonable compensation for the loss which would
be incurred by the Lender due to any such breach. The parties agree that this Section is not intended to in any way limit Lender’s
right to pursue other remedies, including actual damages and/or equitable relief.

 

c.
The Company and Lender hereto acknowledge and agree that the sums payable as Liquidated Damages under subsection 10(a) and 10(b)
above shall constitute liquidated damages and not penalties and are in addition to all other rights of the Lenders, including
the right to call a default under the Securities Purchase Agreement. The parties further acknowledge that (i) the amount of loss
or damages likely to be incurred is incapable or is difficult to precisely estimate, (ii) the amounts specified in such subsections
bear a reasonable relationship to, and are not plainly or grossly disproportionate to, the probable loss likely to be incurred
in connection with any failure by the Company to obtain or maintain the effectiveness of a registration statement, (iii) one of
the reasons for the Company and the Lender reaching an agreement as to such amounts was the uncertainty and cost of litigation
regarding the question of actual damages, and (iv) the Company and the Lender are sophisticated business parties and have been
represented by sophisticated and able legal counsel and negotiated this Agreement at arm’s length.

 

8.
COMMON SHARE ISSUANCE. Upon receipt by the Company of a written request from Lender to convert any amount due under
any Note or to exercise any portion of any Warrant, subject to any limitations on conversion or exercise contained in any Note
and/or Warrant, the Company shall have three (3) business days (“Delivery Date”) to issue the shares of Common Stock
rightfully listed in such request. If the Company fails to timely deliver the shares through willful failure or deliberate hindrance,
the Company shall pay to Lender in immediately available funds $1,000.00 per day past the Delivery Date that the shares are actually
issued. Any amounts due under this Section shall be paid by the fifth (5th) day of the month following the month in
which they accrued or, at the option of Lender, may be added to the principal under any Note. The Company agrees that the right
to convert the Note or exercise its Warrants is a valuable right to Lender and a material consideration of it entering this Agreement.
The parties agree that it would be impracticable and extremely difficult to ascertain the amount of actual damages caused by a
failure of the Company to timely deliver shares as required hereby. Therefore, the parties agree that the foregoing liquidated
damages provision represents reasonable compensation for the loss which would be incurred by the Lender due to any such breach.
The parties agree that this Section is not intended to in any way limit Lender’s right to pursue other remedies, including
actual damages and/or equitable relief.

 

    	Page | 4
	 	 

    	Loan Agreement	 	 

    

 

9.
EVENTS OF DEFAULT. An event of default will occur if any of the following circumstances occur (each an “Event
of Default”):

 

a.
Any representation or warranty made by Company in this Agreement or in connection with any Warrant or Note, or in any financial
statement, or any other statement furnished by Company to Lender is untrue in any material respect at the time when made or becomes
untrue.

 

b.
Default by Company in the observance or performance of any other covenant or agreement contained in this Agreement.

 

c.
Default by Company under the terms of any Note or Warrant or any other third party note or warrant that exceeds a value of $100,000.

 

d.
Filing by Company of a voluntary petition in bankruptcy seeking reorganization, arrangement or readjustment of debts, or any other
relief under the Bankruptcy Code as amended or under any other insolvency act or law, state or federal, now or hereafter existing.

 

e.
Filing of an involuntary petition against Company in bankruptcy seeking reorganization, arrangement or readjustment of debts,
or any other relief under the Bankruptcy Code as amended, or under any other insolvency act or law, state or federal, now or hereafter
existing, and the continuance thereof for sixty (60) days undismissed, unbonded or undischarged.

 

f.
Company liquidates, transfers, sells or assigns substantially its assets or elects to wind down its operations or dissolve.

 

g.
The Company fails to maintain irrevocable TA instruction or file with the Company’s transfer agent along with a reserve
of common shares sufficient to satisfy the Note based on a then hypothetical conversion scenario per the terms of the Note and
the Warrants.

 

h.
The Company fails to maintain DTC or DWAC eligibility.

 

i.
The Company fails to stay current in its SEC reporting obligations, including maintaining XBRL financial information on the Company’s
corporate website.

 

j.
The Company fails to deliver the Lender the shares of Common Stock rightfully listed in any Conversion Notice or any Warrants
Exercise Notice within three (3) business days.

 

k.
The Company breaches any other agreement it has with Lender or his assigns.

 

l.
The Company interferes with Lender’s or its assigns’ efforts to remove the restrictive legend from the Common Stock
issued as a result of conversion of any Note when Lender or his assign has provided an attorney opinion letter opining that the
shares are eligible to have the legend removed pursuant to Rule 144 or otherwise.

 

    	Page | 5
	 	 

    	Loan Agreement	 	 

    

 

m.
The Company fails to prepare and file with the United States Securities and Exchange Commission (the “Commission”)
a registration statement on Form F-1 within 30 days of the Effective Date to cover the Common Stock underlying the Note and Warrants
granted hereto, or the Form F-1 fails be effective within 105 days from the Effective Date.

 

10.
REMEDIES. (i) There will be no cure period available for the Event of Default as defined in Section 11(d), 11(e) and
11(m); or (ii) upon the occurrence of an Event of Default as defined above, and provided such Event of Default as defined in Section
11(a) through 11(c), and Section 11(f) through 11(l), has not been cured by the Company within five (5) business days after the
occurrence of such Event of Default, the principal and any accrued interest of the Note will be due immediately, and Lender shall
have all of the rights and remedies provided by applicable law and equity. To the extent permitted by law, Company waives any
rights to presentment, demand, protest, or notice of any kind in connection with this Agreement, any Warrant and/or any Note.
No failure or delay on the part of Lender in exercising any right, power, or privilege hereunder or thereunder will preclude any
other or further exercise thereof or the exercise of any other right, power, or privilege. The rights and remedies provided herein
are cumulative and not exclusive of any other rights or remedies provided at law or in equity. In the event Lender shall refer
this Agreement to an attorney to enforce the terms hereof, the Company agrees to pay all the costs and expenses incurred in attempting
or effecting the enforcement of the Lender’s rights, including reasonable attorney’s fees, whether or not suit is
instituted.

 

11.
NOTICE. Any and all notices, demands, advance requests or other communications required or desired to be given hereunder
by any party shall be in writing and shall be validly given or made to another party if (i) personally served, (ii) sent by email
on the date such email is sent (provided confirmation of such email being sent is provided upon request) (iii) deposited in the
United States mail, postage prepaid, return receipt requested, or (iv) by facsimile with confirmation receipt. Notice hereunder
is to be given as follows:

 

If
to the Company:

 

Todos
Medical Ltd.

1
Hamada Street

Rehovot,
Israel 2244427

Attn:
Gerald Commissiong

 

If
to the Lender:

 

Ethel
Zielniec

234
Hillhurst BLVD, 

Toronto
ON M5N 1P4

 

12.
GENERAL PROVISIONS. All representations and warranties made in the Transaction Documents shall survive the execution
and delivery of this Agreement and the making of any Loans hereunder. This Agreement will be binding upon and inure to the benefit
of Company and Lender, their respective successors and assigns.

 

13.
ENTIRE AGREEMENT. The Transaction Documents contain the entire agreement of the parties and supersedes and replaces
all prior discussions, negotiations and representations of the parties. No party shall rely upon any oral representations in entering
into this agreement, such oral representations, if any, being expressly denied by the party to whom they are attributed and it
being the intention of the parties to limit the terms of this Agreement to those matters contained herein in writing. However,
incorporated Note shall be deemed controlling at all times with regards to any inconsistent or changed terms or amendments contained
therein.

 

    	Page | 6
	 	 

    	Loan Agreement	 	 

    

 

14.
BINDING EFFECT. This agreement is binding upon and inures to the benefit of the parties hereto, their heirs, personal
representatives, successors and assigns. Lender may assign its rights hereunder without prior permission from the Company.

 

15.
GOVERNING LAW AND CONSENT TO JURISDICTION. This Agreement shall be governed by and construed in accordance with the
laws of the State of Florida, without regard to conflict of law provisions. All disputes arising out of or in connection with
this Agreement, or in respect of any legal relationship associated with or derived from this Agreement, shall only be heard in
any competent court residing in New York, NY. The Company agrees that a final judgment in any such action or proceeding shall
be conclusive and may be enforced in other jurisdictions by suit on the judgment or in any manner provided by law. The Company
further waives any objection to venue in any such action or proceeding on the basis of inconvenient forum. The Company agrees
that any action on or proceeding brought against the Lender shall only be brought in such courts.

 

16.
ATTORNEYS FEES. In the event the Lender hereof shall refer this Agreement to an attorney to enforce the terms hereof,
the Company agrees to pay all the costs and expenses incurred in attempting or effecting the enforcement of the Lender’s
rights, including reasonable attorney’s fees, whether or not suit is instituted.

 

17.
AMENDMENT. The terms of this Agreement may not be amended, modified, or eliminated without written consent of the parties.

 

18.
SEVERABILITY. Every provision of this Agreement is intended to be severable. If any term or provision thereof is illegal
or invalid for any reason whatsoever, such illegality or invalidity shall not affect the validity or legality of the remainder
of this Agreement.

 

19.
CONSTRUCTION. Section and paragraph headings are for convenience only and do not affect the meaning or interpretation
of this Agreement. No rule of construction or interpretation that disfavors the party drafting this Agreement or any of its provisions
will apply to the interpretation of this Agreement. Instead, this Agreement will be interpreted according to the fair meaning
of its terms.

 

20.
FURTHER ASSURANCES. Each party hereto agrees to do all things, including execute, acknowledge and/or deliver any documents
which may be reasonably necessary, appropriate or desirable to effectuate the transactions contemplated herein pursuant to terms
and conditions of this Agreement.

 

IN
WITNESS WHEREOF, the parties hereto enter into this Loan Agreement which is effective as of the date first written.

 

	Company:
    	 	Lender:
	 	 	 	 
	Todos
    Medical Ltd.	 	Ethel
    Zelniec
	 	 	 	 	 
	By:	 	 	By:
    	          
	Name:	Gerald
    Commissiong	 	Name:	 
	Title:	Chief
    Executive Officer	 	Title:	 

 

    	Page | 7
	 	 

    	 	 	 

    

 

EXHIBIT
A

 

NOTE
FORM

 

    	Page | 8
	 	 

    	 	 	 

    

 

EXHIBIT
B

 

WARRANT
FORM

 

    	Page | 9
	 	 

    	 	 	 

    

 

EXHIBIT
C

 

Todos
Medical Ltd

 

Ethel
Zelniec

 

Schedule
of Loan Advances (Additional Sheets may be Attached if Necessary)

 

	Date
    of Loan Advance	 	Amount
    of Loan Advance	 	Total
    of all Loan Advances Owed by Company (Excluding Interest)	 	Initials
    of Lender Representative	 	Initials
    of Authorized Company Representative
	 	 	 	 	 	 	 	 	 
	 	 	 	 	 	 	 	 	 
	 	 	 	 	 	 	 	 	 
	 	 	 	 	 	 	 	 	 
	 	 	 	 	 	 	 	 	 

 

    	Page | 10Exhibit 10.1

 

PURCHASE AGREEMENT

 

PURCHASE AGREEMENT
(the “Agreement”), dated as of August 14, 2020, by and between ODYSSEY GROUP INTERNATIONAL, INC., a Nevada
corporation (the “Company”), and LINCOLN PARK CAPITAL FUND, LLC, an Illinois limited liability company
(the “Investor”).

 

WHEREAS: 

Subject to the terms
and conditions set forth in this Agreement, the Company wishes to sell to the Investor, and the Investor wishes to buy from the
Company, up to Ten Million Two Hundred Fifty Thousand Dollars ($10,250,000) of the Company's common stock, $0.001 par value per
share (the "Common Stock"). The shares of Common Stock to be purchased hereunder (including, without limitation,
the Initial Purchase Shares (as defined herein)) are referred to herein as the “Purchase Shares.”

 

NOW THEREFORE, in consideration
of the mutual covenants contained in this Agreement, and for other good and valuable consideration, the receipt and adequacy of
which are hereby acknowledged, the Company and the Investor hereby agree as follows:

 

1.       CERTAIN
DEFINITIONS. 

 

For purposes of this
Agreement, the following terms shall have the following meanings:

 

(a)       “Accelerated
Purchase Date” means, with respect to any Accelerated Purchase made pursuant to Section 2(c) hereof, the Business
Day immediately following the applicable Purchase Date with respect to the corresponding Regular Purchase referred to in clause
(i) of the second sentence of Section 2(c) hereof.

 

(b)       “Accelerated
Purchase Floor Price” means $0.25, which shall be appropriately adjusted for any reorganization, recapitalization, non-cash
dividend, stock split or other similar transaction and, effective upon the consummation of any such reorganization, recapitalization,
non-cash dividend, stock split or other similar transaction, the Accelerated Purchase Floor Price shall mean the lower of
(i) the adjusted price and (ii) $1.00.

 

(c)       “Accelerated
Purchase Minimum Price Threshold” means, with respect to any Accelerated Purchase made pursuant to Section 2(c)
hereof, the greater of (i) seventy-five percent (75%) of the Closing Sale Price of the Common Stock on the applicable Purchase
Date with respect to the corresponding Regular Purchase referred to in clause (i) of the second sentence of Section 2(c)
hereof and (ii) the minimum per share price threshold set forth by the Company in the applicable Accelerated Purchase Notice.

 

(d)       “Accelerated
Purchase Notice” means, with respect to an Accelerated Purchase made pursuant to Section 2(c) hereof, an irrevocable
written notice from the Company to the Investor directing the Investor to purchase the number of Purchase Shares specified by the
Company therein as the Accelerated Purchase Share Amount to be purchased by the Investor (such specified Accelerated Purchase Share
Amount subject to adjustment in accordance with Section 2(c) hereof as necessary to give effect to the Purchase Share amount
limitations applicable to such Accelerated Purchase Share Amount as set forth in this Agreement) at the applicable Accelerated
Purchase Price on the applicable Accelerated Purchase Date for such Accelerated Purchase.

 

 

 

    	 	1	 

     

    

 

(e)       “Accelerated
Purchase Price” means, with respect to an Accelerated Purchase made pursuant to Section 2(c) hereof, ninety-three
percent (93%) of the lower of (i) the VWAP for the period beginning at 9:30:01 a.m., Eastern time, on the applicable Accelerated
Purchase Date, or such other time publicly announced by the Principal Market as the official open (or commencement) of trading
on the Principal Market on such applicable Accelerated Purchase Date (the “Accelerated Purchase Commencement Time”),
and ending at the earliest of (A) 4:00:00 p.m., Eastern time, on such applicable Accelerated Purchase Date, or such other time
publicly announced by the Principal Market as the official close of trading on the Principal Market on such applicable Accelerated
Purchase Date, (B) such time, from and after the Accelerated Purchase Commencement Time for such Accelerated Purchase, that the
total number (or volume) of shares of Common Stock traded on the Principal Market has exceeded the applicable Accelerated Purchase
Share Volume Maximum, and (C) such time, from and after the Accelerated Purchase Commencement Time for such Accelerated Purchase,
that the Sale Price has fallen below the applicable Accelerated Purchase Minimum Price Threshold (such earliest of (i)(A), (i)(B)
and (i)(C) above, the “Accelerated Purchase Termination Time”), and (ii) the Closing Sale Price of the Common
Stock on such applicable Accelerated Purchase Date (to be appropriately adjusted for any applicable reorganization, recapitalization,
non-cash dividend, stock split, reverse stock split or other similar transaction).

 

(f)       “Accelerated
Purchase Share Amount” means, with respect to an Accelerated Purchase made pursuant to Section 2(c) hereof, the
number of Purchase Shares directed by the Company to be purchased by the Investor in an applicable Accelerated Purchase Notice,
which number of Purchase Shares shall not exceed the lesser of (i) 300% of the number of Purchase Shares directed by the Company
to be purchased by the Investor pursuant to the corresponding Regular Purchase Notice for the corresponding Regular Purchase referred
to in clause (i) of the second sentence of Section 2(c) hereof (such corresponding Regular Purchase being subject to the
Purchase Share limitations contained in Section 2(b) hereof) and (ii) an amount equal to (A) the Accelerated Purchase Share
Percentage multiplied by (B) the total number (or volume) of shares of Common Stock traded on the Principal Market during the period
on the applicable Accelerated Purchase Date beginning at the Accelerated Purchase Commencement Time for such Accelerated Purchase
and ending at the Accelerated Purchase Termination Time for such Accelerated Purchase.

 

(g)       “Accelerated
Purchase Share Percentage” means, with respect to an Accelerated Purchase made pursuant to Section 2(c) hereof,
thirty percent (30%).

 

(h)       “Accelerated
Purchase Share Volume Maximum” means, with respect to an Accelerated Purchase made pursuant to Section 2(c) hereof,
a number of shares of Common Stock equal to (i) the number of Purchase Shares specified by the Company in the applicable Accelerated
Purchase Notice as the Accelerated Purchase Share Amount to be purchased by the Investor in such Accelerated Purchase, divided
by (ii) the Accelerated Purchase Share Percentage (to be appropriately adjusted for any applicable reorganization, recapitalization,
non-cash dividend, stock split, reverse stock split or other similar transaction).

 

(i)       “Additional
Accelerated Purchase Date” means, with respect to an Additional Accelerated Purchase made pursuant to Section 2(d)
hereof, the Business Day (i) that is the Accelerated Purchase Date with respect to the corresponding Accelerated Purchase referred
to in clause (i) of the proviso in the second sentence of Section 2(d) hereof and (ii) on which the Investor receives, prior
to 1:00 p.m., Eastern time, on such Business Day, a valid Additional Accelerated Purchase Notice for such Additional Accelerated
Purchase in accordance with this Agreement.

 

(j)       “Additional
Accelerated Purchase Floor Price” means $0.25, which shall be appropriately adjusted for any reorganization, recapitalization,
non-cash dividend, stock split or other similar transaction and, effective upon the consummation of any such reorganization, recapitalization,
non-cash dividend, stock split or other similar transaction, the Additional Accelerated Purchase Floor Price shall mean the lower
of (i) the adjusted price and (ii) $1.00.

 

 

 

    	 	2	 

     

    

 

(k)       “Additional
Accelerated Purchase Minimum Price Threshold” means, with respect to an Additional Accelerated Purchase made pursuant
to Section 2(d) hereof, the greater of (i) seventy-five percent (75%) of the Closing Sale Price of the Common Stock on the
Business Day immediately preceding the applicable Additional Accelerated Purchase Date with respect to such Additional Accelerated
Purchase and (ii) the minimum per share price threshold set forth by the Company in the applicable Additional Accelerated Purchase
Notice.

 

(l)       “Additional
Accelerated Purchase Notice” means, with respect to an Additional Accelerated Purchase made pursuant to Section 2(d)
hereof, an irrevocable written notice from the Company to the Investor directing the Investor to purchase the number of Purchase
Shares specified by the Company therein as the Additional Accelerated Purchase Share Amount to be purchased by the Investor (such
specified Additional Accelerated Purchase Share Amount subject to adjustment in accordance with Section 2(d) hereof as necessary
to give effect to the Purchase Share amount limitations applicable to such Additional Accelerated Purchase Share Amount as set
forth in this Agreement) at the applicable Additional Accelerated Purchase Price on the applicable Additional Accelerated Purchase
Date for such Additional Accelerated Purchase.

 

(m)       “Additional
Accelerated Purchase Price” means, with respect to an Additional Accelerated Purchase made pursuant to Section 2(d)
hereof, ninety-three percent (93%) of the lower of (i) the VWAP for the period on the applicable Additional Accelerated Purchase
Date, beginning at the latest of (A) the applicable Accelerated Purchase Termination Time with respect to the corresponding Accelerated
Purchase referred to in clause (i) of the proviso in the second sentence of Section 2(d) hereof on such Additional Accelerated
Purchase Date, (B) the applicable Additional Accelerated Purchase Termination Time with respect to the most recently completed
prior Additional Accelerated Purchase on such Additional Accelerated Purchase Date, as applicable, and (C) the time at which all
Purchase Shares subject to all prior Accelerated Purchases and Additional Accelerated Purchases (as applicable), including, without
limitation, those that have been effected on the same Business Day as the applicable Additional Accelerated Purchase Date with
respect to which the applicable Additional Accelerated Purchase relates, have theretofore been received by the Investor as DWAC
Shares in accordance with this Agreement (such latest of (i)(A), (i)(B) and (i)(C) above, the “Additional Accelerated
Purchase Commencement Time”), and ending at the earliest of (X) 4:00 p.m., Eastern time, on such Additional Accelerated
Purchase Date, or such other time publicly announced by the Principal Market as the official close of trading on the Principal
Market on such Additional Accelerated Purchase Date, (Y) such time, from and after the Additional Accelerated Purchase Commencement
Time for such Additional Accelerated Purchase, that total number (or volume) of shares of Common Stock traded on the Principal
Market has exceeded the applicable Additional Accelerated Purchase Share Volume Maximum, and (Z) such time, from and after the
Additional Accelerated Purchase Commencement Time for such Additional Accelerated Purchase, that the Sale Price has fallen below
the applicable Additional Accelerated Purchase Minimum Price Threshold (such earliest of (i)(X), (i)(Y) and (i)(Z) above, the “Additional
Accelerated Purchase Termination Time”), and (ii) the Closing Sale Price of the Common Stock on such Additional Accelerated
Purchase Date (to be appropriately adjusted for any applicable reorganization, recapitalization, non-cash dividend, stock split,
reverse stock split or other similar transaction).

 

(n)       “Additional
Accelerated Purchase Share Amount” means, with respect to an Additional Accelerated Purchase made pursuant to Section
2(d) hereof, the number of Purchase Shares directed by the Company to be purchased by the Investor on an Additional Accelerated
Purchase Notice, which number of Purchase Shares shall not exceed the lesser of (i) 300% of the number of Purchase Shares directed
by the Company to be purchased by the Investor pursuant to the corresponding Regular Purchase Notice for the corresponding Regular
Purchase referred to in clause (i) of the proviso in the second sentence of Section 2(d) hereof (such corresponding Regular
Purchase being subject to the Purchase Share limitations contained in Section 2(b) hereof) and (ii) an amount equal to (A)
the Additional Accelerated Purchase Share Percentage multiplied by (B) the total number (or volume) of shares of Common Stock traded
on the Principal Market during the period on the applicable Additional Accelerated Purchase Date beginning at the Additional Accelerated
Purchase Commencement Time for such Additional Accelerated Purchase and ending at the Additional Accelerated Purchase Termination
Time for such Additional Accelerated Purchase.

 

 

 

    	 	3	 

     

    

 

(o)       “Additional
Accelerated Purchase Share Percentage” means, with respect to an Additional Accelerated Purchase made pursuant to Section
2(d) hereof, thirty percent (30%).

 

(p)       “Additional
Accelerated Purchase Share Volume Maximum” means, with respect to an Additional Accelerated Purchase made pursuant to
Section 2(d) hereof, a number of shares of Common Stock equal to (i) the number of Purchase Shares specified by the Company
in the applicable Additional Accelerated Purchase Notice as the Additional Accelerated Purchase Share Amount to be purchased by
the Investor in such Additional Accelerated Purchase, divided by (ii) the Additional Accelerated Purchase Share Percentage (to
be appropriately adjusted for any applicable reorganization, recapitalization, non-cash dividend, stock split, reverse stock split
or other similar transaction).

 

(q)       “Alternate
Adjusted Regular Purchase Share Limit” means, with respect to a Regular Purchase made pursuant to Section 2(b)
hereof, the maximum number of Purchase Shares which, taking into account the applicable per share Purchase Price therefor calculated
in accordance with this Agreement, would enable the Company to deliver to the Investor, on the applicable Purchase Date for such
Regular Purchase, a Regular Purchase Notice for a Purchase Amount equal to, or as closely approximating without exceeding, Seventy-Five
Thousand Dollars ($75,000).

 

(r)        “Available
Amount” means, initially, Ten Million Two Hundred Fifty Thousand Dollars ($10,250,000) in the aggregate, which amount
shall be reduced by (i) the Initial Purchase Amount upon the purchase of the Initial Purchase Shares by the Investor on the date
hereof pursuant to Section 2(a) hereof, and (ii) the Purchase Amount each time the Investor purchases Purchase Shares (other
than the Initial Purchase Shares) pursuant to Section 2 hereof.

 

(s)       “Bankruptcy
Law” means Title 11, U.S. Code, or any similar federal or state law for the relief of debtors.

 

(t)       “Business
Day” means any day on which the Principal Market is open for trading, including any day on which the Principal Market
is open for trading for a period of time less than the customary time.

 

(u)       “Closing
Sale Price” means, for any security as of any date, the last closing sale price for such security on the Principal Market
as reported by the Principal Market.

 

(v)       “Confidential
Information” means any information disclosed by either party to the other party, either directly or indirectly, in writing,
orally or by inspection of tangible objects (including, without limitation, documents, prototypes, samples, plant and equipment),
which is designated as "Confidential," "Proprietary" or some similar designation. Information communicated
orally shall be considered Confidential Information if such information is confirmed in writing as being Confidential Information
within ten (10) Business Days after the initial disclosure. Confidential Information may also include information disclosed to
a disclosing party by third parties. Confidential Information shall not, however, include any information which (i) was publicly
known and made generally available in the public domain prior to the time of disclosure by the disclosing party; (ii) becomes publicly
known and made generally available after disclosure by the disclosing party to the receiving party through no action or inaction
of the receiving party; (iii) is already in the possession of the receiving party without confidential restriction at the time
of disclosure by the disclosing party as shown by the receiving party’s files and records immediately prior to the time of
disclosure; (iv) is obtained by the receiving party from a third party without a breach of such third party’s obligations
of confidentiality; (v) is independently developed by the receiving party without use of or reference to the disclosing party’s
Confidential Information, as shown by documents and other competent evidence in the receiving party’s possession; or (vi)
is required by law to be disclosed by the receiving party, provided that the receiving party gives the disclosing party prompt
written notice of such requirement prior to such disclosure and assistance in obtaining an order protecting the information from
public disclosure.

 

 

 

    	 	4	 

     

    

 

(w)       “Custodian”
means any receiver, trustee, assignee, liquidator or similar official under any Bankruptcy Law.

 

(x)       “DTC”
means The Depository Trust Company, or any successor performing substantially the same function for the Company.

(y)       “DWAC
Shares” means shares of Common Stock that are (i) issued in electronic form, (ii) freely tradable and transferable and
without restriction on resale and (iii) timely credited by the Company to the Investor’s or its designee’s specified
Deposit/Withdrawal at Custodian (DWAC) account with DTC under its Fast Automated Securities Transfer (FAST) Program, or any similar
program hereafter adopted by DTC performing substantially the same function.

(z)        “Exchange
Act” means the Securities Exchange Act of 1934, as amended, and the rules and regulations promulgated by the SEC thereunder.

 

(aa)“Fully
Adjusted Regular Purchase Share Limit” means, with respect to any reorganization, recapitalization, non-cash dividend,
stock split or other similar transaction from and after the date of this Agreement, the Regular Purchase Share Limit (as defined
in Section 2(b) hereof) in effect on the applicable date of determination, after giving effect to the full proportionate
adjustment thereto made pursuant to Section 2(b) hereof for or in respect of such reorganization, recapitalization, non-cash
dividend, stock split or other similar transaction.

 

(bb)“Material
Adverse Effect” means any material adverse effect on (i) the enforceability of any Transaction Document, (ii) the
results of operations, assets, business or financial condition of the Company and its Subsidiaries, taken as a whole, other than
any material adverse effect that resulted exclusively from (A) any change in the United States or foreign economies or securities
or financial markets in general that does not have a disproportionate effect on the Company and its Subsidiaries, taken as a whole,
(B) any change that generally affects the industry in which the Company and its Subsidiaries operate that does not have a
disproportionate effect on the Company and its Subsidiaries, taken as a whole, (C) any change arising in connection with earthquakes,
hostilities, acts of war, sabotage or terrorism or military actions or any escalation or material worsening of any such hostilities,
acts of war, sabotage or terrorism or military actions existing as of the date hereof, (D) any action taken by the Investor,
its affiliates or its or their successors and assigns with respect to the transactions contemplated by this Agreement, (E) the
effect of any change in applicable laws or accounting rules that does not have a disproportionate effect on the Company and its
Subsidiaries, taken as a whole, or (F) any change resulting from compliance with terms of this Agreement or the consummation
of the transactions contemplated by this Agreement, or (iii) the Company’s ability to perform in any material respect
on a timely basis its obligations under any Transaction Document to be performed as of the date of determination.

 

(cc)“Maturity
Date” means the first day of the month immediately following the thirty-six (36) month anniversary of the Commencement
Date.

 

(dd)“PEA
Period” means the period commencing at 9:30 a.m., Eastern time, on the fifth (5th) Business Day immediately
prior to the filing of any post-effective amendment to the Registration Statement (as defined herein) or New Registration Statement
(as such term is defined in the Registration Rights Agreement), and ending at 9:30 a.m., Eastern time, on the Business Day immediately
following, the effective date of any post-effective amendment to the Registration Statement (as defined herein) or New Registration
Statement (as such term is defined in the Registration Rights Agreement).

 

(ee)“Person”
means an individual or entity including but not limited to any limited liability company, a partnership, a joint venture, a corporation,
a trust, an unincorporated organization and a government or any department or agency thereof.

 

 

 

    	 	5	 

     

    

 

(ff)“Principal
Market” means the OTCQB operated by the OTC Markets Group, Inc. (or any nationally recognized successor thereto); provided,
however, that in the event the Company’s Common Stock is ever listed or traded on The Nasdaq Capital Market, The Nasdaq Global
Market, The Nasdaq Global Select Market, the New York Stock Exchange, the NYSE American, the NYSE Arca, the OTC Bulletin Board,
or the OTCQX operated by the OTC Markets Group, Inc. (or any nationally recognized successor to any of the foregoing), then the
“Principal Market” shall mean such other market or exchange on which the Company’s Common Stock is then listed
or traded.

 

(gg)“Purchase
Amount” means, with respect to the Initial Purchase, any Regular Purchase, any Accelerated Purchase, and any Additional
Accelerated Purchase made hereunder, as applicable, the portion of the Available Amount to be purchased by the Investor pursuant
to Section 2 hereof.

 

(hh)“Purchase
Date” means, with respect to a Regular Purchase made pursuant to Section 2(b) hereof, the Business Day on which
the Investor receives, after 4:00 p.m., Eastern time, but prior to 5:00 p.m., Eastern time, on such Business Day, a valid Regular
Purchase Notice for such Regular Purchase in accordance with this Agreement.

 

(ii)       “Purchase
Price” means, with respect to a Regular Purchase made pursuant to Section 2(b) hereof, the lower of: (i) the lowest
Sale Price on the Purchase Date for such Regular Purchase and (ii) the arithmetic average of the three (3) lowest Closing Sale
Prices for the Common Stock during the twelve (12) consecutive Business Days ending on the Business Day immediately preceding such
Purchase Date for such Regular Purchase (in each case, to be appropriately adjusted for any reorganization, recapitalization, non-cash
dividend, stock split or other similar transaction that occurs on or after the date of this Agreement).

 

(jj)“Regular
Purchase Floor Price” means $0.20, which shall be appropriately adjusted for any reorganization, recapitalization, non-cash
dividend, stock split or other similar transaction and, effective upon the consummation of any such reorganization, recapitalization,
non-cash dividend, stock split or other similar transaction, the Regular Purchase Floor Price shall mean the lower of (i)
the adjusted price and (ii) $1.00.

 

(kk)“Regular
Purchase Notice” means, with respect to a Regular Purchase pursuant to Section 2(b) hereof, an irrevocable written
notice from the Company to the Investor directing the Investor to buy a specified number of Purchase Shares (subject to the Purchase
Share limitations contained in Section 2(b) hereof) at the applicable Purchase Price for such Regular Purchase in accordance
with this Agreement.

 

(ll)“Sale
Price” means any trade price for the shares of Common Stock on the Principal Market as reported by the Principal Market.

 

(mm)“SEC”
means the U.S. Securities and Exchange Commission.

 

(nn)“Securities”
means, collectively, the Purchase Shares and the Commitment Shares.

 

 

 

    	 	6	 

     

    

 

(oo)       “Securities
Act” means the Securities Act of 1933, as amended, and the rules and regulations promulgated by the SEC thereunder.

 

(pp)“Subsidiary”
means any Person the Company wholly-owns or controls, or in which the Company, directly or indirectly, owns a majority of the voting
stock or similar voting interest, in each case that would be disclosable pursuant to Item 601(b)(21) of Regulation S-K promulgated
under the Securities Act.

 

(qq)“Transaction
Documents” means, collectively, this Agreement and the schedules and exhibits hereto, the Registration Rights Agreement
and the schedules and exhibits thereto, and each of the other agreements, documents, certificates and instruments entered into
or furnished by the parties hereto or thereto in connection with the transactions contemplated hereby and thereby.

 

(rr) “Transfer
Agent” means Empire Stock Transfer, or such other Person who is then serving as the transfer agent for the Company in
respect of the Common Stock.

 

(ss)“VWAP”
means in respect of an Accelerated Purchase Date or an Additional Accelerated Purchase Date, as applicable, the volume weighted
average price of the Common Stock on the Principal Market, as reported on the Principal Market.

 

2. PURCHASE OF COMMON STOCK. 

 

Subject to the terms
and conditions set forth in this Agreement, the Company has the right to sell to the Investor, and the Investor has the obligation
to purchase from the Company, Purchase Shares as follows:

 

(a)       Initial
Purchase. On the date of this Agreement, upon the satisfaction of the conditions set forth in Sections 7(I) and 8(I)
hereof, the Company shall issue and sell to the Investor and the Investor shall purchase from the Company (such purchase, the “Initial
Purchase”) Six Hundred Two Thousand Four Hundred Twenty-Two (602,422) Purchase Shares (collectively, the “Initial
Purchase Shares”) for aggregate consideration of Two Hundred Fifty Thousand Dollars ($250,000) (the “Initial
Purchase Amount”).

 

 

 

    	 	7	 

     

    

 

(b)       Commencement
of Regular Sales of Common Stock. Upon the satisfaction of all of the conditions set forth in Sections 7(II) and 8(II)
hereof (the “Commencement” and the date of satisfaction of such conditions the “Commencement Date”)
and thereafter, the Company shall have the right, but not the obligation, to direct the Investor, by its delivery to the Investor
of a Regular Purchase Notice from time to time, to purchase up to One Hundred Thousand (100,000) Purchase Shares, subject to adjustment
as set forth below in this Section 2(b) (such maximum number of Purchase Shares, as may be adjusted from time to time, the
“Regular Purchase Share Limit”), at the Purchase Price on the Purchase Date (each such purchase a “Regular
Purchase”); provided, however, that (i) the Regular Purchase Share Limit shall be increased to One Hundred
Fifty Thousand (150,000) Purchase Shares, if the Closing Sale Price of the Common Stock on the applicable Purchase Date is not
below $1.00, and (ii) the Regular Purchase Share Limit shall be increased to Two Hundred Thousand (200,000) Purchase Shares, if
the Closing Sale Price of the Common Stock on the applicable Purchase Date is not below $1.50 (all of which share and dollar amounts
shall be appropriately proportionately adjusted for any reorganization, recapitalization, non-cash dividend, stock split or other
similar transaction; provided that if, after giving effect to the full proportionate adjustment to the Regular Purchase
Share Limit therefor, the Fully Adjusted Regular Purchase Share Limit then in effect would preclude the Company from delivering
to the Investor a Regular Purchase Notice hereunder for a Purchase Amount (calculated by multiplying (X) the number of Purchase
Shares equal to the Fully Adjusted Regular Purchase Share Limit, by (Y) the Purchase Price per Purchase Share covered by such Regular
Purchase Notice on the applicable Purchase Date therefor) equal to or greater than Seventy-Five Thousand Dollars ($75,000), the
Regular Purchase Share Limit for such Regular Purchase Notice shall not be fully adjusted to equal the applicable Fully Adjusted
Regular Purchase Share Limit, but rather the Regular Purchase Share Limit for such Regular Purchase Notice shall be adjusted to
equal the applicable Alternate Adjusted Regular Purchase Share Limit as of the applicable Purchase Date for such Regular Purchase
Notice); and provided, further, however, that the Investor’s committed obligation under any single Regular
Purchase (other than any Regular Purchase with respect to which an Alternate Adjusted Regular Purchase Share Limit shall apply)
shall not exceed Fifty Thousand Dollars ($50,000), unless the median aggregate dollar value of the volume of shares of Common Stock
traded on the Principal Market during the twenty (20) consecutive trading day period ending on the Purchase Date of the applicable
Regular Purchase equals or exceeds One Hundred Thousand Dollars ($100,000), in which case the Investor’s committed obligation
under such single Regular Purchase (other than any Regular Purchase with respect to which an Alternate Adjusted Regular Purchase
Share Limit shall apply) shall not exceed Five Hundred Thousand Dollars ($500,000). If the Company delivers any Regular Purchase
Notice for a Purchase Amount in excess of the limitations contained in the immediately preceding sentence, such Regular Purchase
Notice shall be void ab initio to the extent of the amount by which the number of Purchase Shares set forth in such Regular
Purchase Notice exceeds the number of Purchase Shares which the Company is permitted to include in such Purchase Notice in accordance
herewith, and the Investor shall have no obligation to purchase such excess Purchase Shares in respect of such Regular Purchase
Notice; provided, however, that the Investor shall remain obligated to purchase the number of Purchase Shares which
the Company is permitted to include in such Regular Purchase Notice. The Company may deliver a Regular Purchase Notice to the Investor
as often as every Business Day, so long as (i) the Closing Sale Price of the Common Stock on such Business Day is not less than
the Regular Purchase Floor Price and (ii) all Purchase Shares subject to all prior Regular Purchases have theretofore been received
by the Investor as DWAC Shares in accordance with this Agreement. Notwithstanding the foregoing, the Company shall not deliver
any Regular Purchase Notices to the Investor during the PEA Period.

 

 

 

 

    	 	8	 

     

    

 

(c)       Accelerated
Purchases. Subject to the terms and conditions of this Agreement, from and after the Commencement Date, in addition to purchases
of Purchase Shares as described in Section 2(a) and Section 2(b) above, the Company shall also have the right, but
not the obligation, to direct the Investor, by its delivery to the Investor of an Accelerated Purchase Notice from time to time
in accordance with this Agreement, to purchase the applicable Accelerated Purchase Share Amount at the Accelerated Purchase Price
on the Accelerated Purchase Date therefor in accordance with this Agreement (each such purchase, an “Accelerated Purchase”).
The Company may deliver an Accelerated Purchase Notice to the Investor only on a Purchase Date on which (i) the Company also properly
submitted a Regular Purchase Notice providing for a Regular Purchase of a number of Purchase Shares not less than the Regular Purchase
Share Limit then in effect on such Purchase Date in accordance with this Agreement (including, without limitation, giving effect
to any automatic increase to the Regular Purchase Share Limit as a result of the Closing Sale Price of the Common Stock exceeding
certain thresholds set forth in Section 2(b) above on such Purchase Date and any other adjustments to the Regular Purchase
Share Limit, in each case pursuant to Section 2(b) above) and (ii) the Closing Sale Price of the Common Stock is not less
than the Accelerated Purchase Floor Price. If the Company delivers any Accelerated Purchase Notice directing the Investor to purchase
an amount of Purchase Shares that exceeds the Accelerated Purchase Share Amount that the Company is then permitted to include in
such Accelerated Purchase Notice, such Accelerated Purchase Notice shall be void ab initio to the extent of the amount by
which the number of Purchase Shares set forth in such Accelerated Purchase Notice exceeds the Accelerated Purchase Share Amount
that the Company is then permitted to include in such Accelerated Purchase Notice (which shall be confirmed in an Accelerated Purchase
Confirmation), and the Investor shall have no obligation to purchase such excess Purchase Shares in respect of such Accelerated
Purchase Notice; provided, however, that the Investor shall remain obligated to purchase the Accelerated Purchase
Share Amount which the Company is permitted to include in such Accelerated Purchase Notice. Within one (1) Business Day after completion
of each Accelerated Purchase Date for an Accelerated Purchase, the Investor shall provide to the Company a written confirmation
of such Accelerated Purchase setting forth the applicable Accelerated Purchase Share Amount and Accelerated Purchase Price for
such Accelerated Purchase (each, an “Accelerated Purchase Confirmation”). Notwithstanding the foregoing, the
Company shall not deliver any Accelerated Purchase Notices to the Investor during the PEA Period.

 

(d)       Additional
Accelerated Purchases. Subject to the terms and conditions of this Agreement, from and after the Commencement Date, in addition
to purchases of Purchase Shares as described in Section 2(a), Section 2(b) and Section 2(c) above, the Company
shall also have the right, but not the obligation, to direct the Investor, by its timely delivery to the Investor of an Additional
Accelerated Purchase Notice on an Additional Accelerated Purchase Date in accordance with this Agreement, to purchase the applicable
Additional Accelerated Purchase Share Amount at the applicable Additional Accelerated Purchase Price therefor in accordance with
this Agreement (each such purchase, an “Additional Accelerated Purchase”). The Company may deliver multiple
Additional Accelerated Purchase Notices to the Investor on an Additional Accelerated Purchase Date; provided, however,
that the Company may deliver an Additional Accelerated Purchase Notice to the Investor only (i) on a Business Day that is also
the Accelerated Purchase Date for an Accelerated Purchase with respect to which the Company properly submitted to the Investor
an Accelerated Purchase Notice in accordance with this Agreement on the applicable Purchase Date for a Regular Purchase of a number
of Purchase Shares not less than the Regular Purchase Share Limit then in effect in accordance with this Agreement (including,
without limitation, giving effect to any automatic increase to the Regular Purchase Share Limit as a result of the Closing Sale
Price of the Common Stock exceeding certain thresholds set forth in Section 2(b) above on such Purchase Date and any other
adjustments to the Regular Purchase Share Limit, in each case pursuant to Section 2(b) above), (ii) if the Closing Sale
Price of the Common Stock on the Business Day immediately preceding the Business Day on which such Additional Accelerated Purchase
Notice is delivered is not less than the Additional Accelerated Purchase Floor Price, and (iii) if all Purchase Shares subject
to all prior Regular Purchases, Accelerated Purchases and Additional Accelerated Purchases, including, without limitation, those
that have been effected on the same Business Day as the applicable Additional Accelerated Purchase Date with respect to which the
applicable Additional Accelerated Purchase relates, in each case have theretofore been received by the Investor as DWAC Shares
in accordance with this Agreement. If the Company delivers any Additional Accelerated Purchase Notice directing the Investor to
purchase an amount of Purchase Shares that exceeds the Additional Accelerated Purchase Share Amount that the Company is then permitted
to include in such Additional Accelerated Purchase Notice, such Additional Accelerated Purchase Notice shall be void ab initio
to the extent of the amount by which the number of Purchase Shares set forth in such Additional Accelerated Purchase Notice exceeds
the Additional Accelerated Purchase Share Amount that the Company is then permitted to include in such Additional Accelerated Purchase
Notice (which shall be confirmed in an Additional Accelerated Purchase Confirmation), and the Investor shall have no obligation
to purchase such excess Purchase Shares in respect of such Additional Accelerated Purchase Notice; provided, however,
that the Investor shall remain obligated to purchase the Additional Accelerated Purchase Share Amount which the Company is permitted
to include in such Additional Accelerated Purchase Notice. Within one (1) Business Day after completion of each Additional Accelerated
Purchase Date, the Investor will provide to the Company a written confirmation of each Additional Accelerated Purchase on such
Additional Accelerated Purchase Date setting forth the applicable Additional Accelerated Purchase Share Amount and Additional Accelerated
Purchase Price for each such Additional Accelerated Purchase on such Additional Accelerated Purchase Date (each, an “Additional
Accelerated Purchase Confirmation”). Notwithstanding the foregoing, the Company shall not deliver any Additional Accelerated
Purchase Notices to the Investor during the PEA Period.

 

 

 

    	 	9	 

     

    

 

(e)       
Payment for Purchase Shares. For the Initial Purchase and each Regular Purchase, the Investor shall pay to the Company an
amount equal to the Purchase Amount with respect to such Regular Purchase and Initial Purchase, respectively, as full payment for
such Purchase Shares via wire transfer of immediately available funds on the same Business Day that the Investor receives such
Purchase Shares, if such Purchase Shares are received by the Investor before 1:00 p.m., Eastern time, or, if such Purchase Shares
are received by the Investor after 1:00 p.m., Eastern time, the next Business Day. For each Accelerated Purchase and each Additional
Accelerated Purchase, the Investor shall pay to the Company an amount equal to the Purchase Amount with respect to such Accelerated
Purchase and Additional Accelerated Purchase, respectively, as full payment for such Purchase Shares via wire transfer of immediately
available funds on the second Business Day following the date that the Investor receives such Purchase Shares. If the Company or
the Transfer Agent shall fail for any reason or for no reason to electronically transfer any Purchase Shares as DWAC Shares in
respect of a Regular Purchase, an Accelerated Purchase or an Additional Accelerated Purchase (as applicable) within two (2) Business
Days following the receipt by the Company of the Purchase Price, Accelerated Purchase Price and Additional Accelerated Purchase
Price, respectively, therefor in compliance with this Section 2(e), and if on or after such Business Day the Investor purchases
(in an open market transaction or otherwise) shares of Common Stock to deliver in satisfaction of a sale by the Investor of such
Purchase Shares that the Investor anticipated receiving from the Company in respect of such Regular Purchase, Accelerated Purchase
or Additional Accelerated Purchase (as applicable), then the Company shall, within two (2) Business Days after the Investor’s
request, either (i) pay cash to the Investor in an amount equal to the Investor’s total purchase price (including brokerage
commissions, if any) for the shares of Common Stock so purchased (the “Cover Price”), at which point the Company’s
obligation to deliver such Purchase Shares as DWAC Shares shall terminate, or (ii) promptly honor its obligation to deliver to
the Investor such Purchase Shares as DWAC Shares and pay cash to the Investor in an amount equal to the excess (if any) of the
Cover Price over the total Purchase Amount paid by the Investor pursuant to this Agreement for all of the Purchase Shares to be
purchased by the Investor in connection with such Regular Purchase, Accelerated Purchase and Additional Accelerated Purchase (as
applicable). The Company shall not issue any fraction of a share of Common Stock upon the Initial Purchase or any Regular Purchase,
Accelerated Purchase or Additional Accelerated Purchase. If the issuance would result in the issuance of a fraction of a share
of Common Stock, the Company shall round such fraction of a share of Common Stock up or down to the nearest whole share. All payments
made under this Agreement shall be made in lawful money of the United States of America or wire transfer of immediately available
funds to such account as the Company may from time to time designate by written notice in accordance with the provisions of this
Agreement. Whenever any amount expressed to be due by the terms of this Agreement is due on any day that is not a Business Day,
the same shall instead be due on the next succeeding day that is a Business Day.

 

(f)       Beneficial
Ownership Limitation. Notwithstanding anything to the contrary contained in this Agreement, the Company shall not issue
or sell, and the Investor shall not purchase or acquire, any shares of Common Stock under this Agreement which, when
aggregated with all other shares of Common Stock then beneficially owned by the Investor and its affiliates (as calculated pursuant
to Section 13(d) of the Exchange Act and Rule 13d-3 promulgated thereunder), would result in the beneficial ownership by the Investor of
more than 4.99% of the outstanding shares of Common Stock (the “Beneficial Ownership Limitation”). Upon
the written or oral request of the Investor, the Company shall promptly (but not later than 24 hours) confirm orally or in writing
to the Investor the number of shares of Common Stock then outstanding. The Investor and the Company shall each cooperate in good
faith in the determinations required hereby and the application hereof. The Investor’s written certification to the Company
of the applicability of the Beneficial Ownership Limitation, and the resulting effect thereof hereunder at any time, shall be conclusive
with respect to the applicability thereof and such result absent manifest error.

 

 

 

    	 	10	 

     

    

 

3.       INVESTOR'S
REPRESENTATIONS AND WARRANTIES.

 

The Investor represents
and warrants to the Company that as of the date hereof and as of the Commencement Date:

 

(a)       Investment
Purpose.  The Investor is acquiring the Securities as principal for its own account and not with a view to or for distributing
or reselling such Securities or any part thereof in violation of the Securities Act or any applicable state securities law, has
no present intention of distributing any of such Securities in violation of the Securities Act or any applicable state securities
law and has no direct or indirect arrangement or understandings with any other Persons to distribute or regarding the distribution
of such Securities in violation of the Securities Act or any applicable state securities law (this representation and warranty
not limiting the Investor’s right to sell the Securities at any time pursuant to the Registration Statement described herein
or otherwise in compliance with applicable federal and state securities laws).  The Investor is acquiring the Securities
hereunder in the ordinary course of its business.

 

(b)       Accredited
Investor Status. The Investor is an "accredited investor" as that term is defined in Rule 501(a)(3) of Regulation
D promulgated under the Securities Act.

 

(c)       Reliance
on Exemptions. The Investor understands that the Securities are being offered and sold to it in reliance on specific exemptions
from the registration requirements of United States federal and state securities laws and that the Company is relying in part upon
the truth and accuracy of, and the Investor's compliance with, the representations, warranties, agreements, acknowledgments and
understandings of the Investor set forth herein in order to determine the availability of such exemptions and the eligibility of
the Investor to acquire the Securities.

 

(d)       Information.
The Investor understands that its investment in the Securities involves a high degree of risk. The Investor (i) is able to bear
the economic risk of an investment in the Securities including a total loss thereof, (ii) has such knowledge and experience in
financial and business matters that it is capable of evaluating the merits and risks of the proposed investment in the Securities
and (iii) has had an opportunity to ask questions of and receive answers from the officers of the Company concerning the financial
condition and business of the Company and others matters related to an investment in the Securities. Neither such inquiries nor
any other due diligence investigations conducted by the Investor or its representatives shall modify, amend or affect the Investor's
right to rely on the Company's representations and warranties contained in Section 4 below. The Investor has sought such accounting,
legal and tax advice from its own independent advisors as it has considered necessary to make an informed investment decision with
respect to its acquisition of the Securities and is not relying on any accounting, legal, tax or other advise from the Company,
its officers, directors, representatives or advisors.

 

(e)       No
Governmental Review. The Investor understands that no U.S. federal or state agency or any other government or governmental
agency has passed on or made any recommendation or endorsement of the Securities or the fairness or suitability of an investment
in the Securities nor have such authorities passed upon or endorsed the merits of the offering of the Securities.

 

 

 

    	 	11	 

     

    

 

(f)       Transfer
or Sale. The Investor understands that (i) the Securities may not be offered for sale, sold, assigned or transferred unless
(A) registered pursuant to the Securities Act or (B) an exemption exists permitting such Securities to be sold, assigned or transferred
without such registration; (ii) any sale of the Securities made in reliance on Rule 144 may be made only in accordance with the
terms of Rule 144 and further, if Rule 144 is not applicable, any resale of the Securities under circumstances in which the seller
(or the Person through whom the sale is made) may be deemed to be an underwriter (as that term is defined in the Securities Act)
may require compliance with some other exemption under the Securities Act or the rules and regulations of the SEC thereunder.

 

(g)       Validity;
Enforcement. This Agreement has been duly and validly authorized, executed and delivered on behalf of the Investor and is a
valid and binding agreement of the Investor enforceable against the Investor in accordance with its terms, subject as to enforceability
to general principles of equity and to applicable bankruptcy, insolvency, reorganization, moratorium, liquidation and other similar
laws relating to, or affecting generally, the enforcement of applicable creditors' rights and remedies.

 

(h)       Residency.
The Investor is a resident of the State of Illinois.

 

(i)       No
Short Selling. The Investor represents and warrants to the Company that at no time prior to the date of this Agreement has
any of the Investor, its agents, representatives or affiliates engaged in or effected, in any manner whatsoever, directly or indirectly,
any (i) "short sale" (as such term is defined in Rule 200 of Regulation SHO of the Exchange Act) of the Common Stock
or (ii) hedging transaction, which establishes a net short position with respect to the Common Stock.

 

4.       REPRESENTATIONS
AND WARRANTIES OF THE COMPANY.

 

The Company represents
and warrants to the Investor that, except as set forth in the disclosure schedules attached hereto or in the SEC Documents expressly
referred to as exceptions or qualifications with respect to specific representations and warranties of the Company in this Section
4 (in each case, which exceptions shall be deemed to be a part of the representations and warranties made hereunder), as of the
date hereof and as of the Commencement Date:

 

(a)       Organization
and Qualification. The Company and each of its Subsidiaries is an entity duly incorporated or otherwise organized, validly
existing and in good standing under the laws of the jurisdiction of its incorporation or organization, with the requisite corporate
power and authority to own and use its properties and assets and to carry on its business as currently conducted.  Neither
the Company nor any of its Subsidiaries is in violation or default of any of the provisions of its respective certificate or Articles
of Incorporation, bylaws or other organizational or charter documents.  Each of the Company and its Subsidiaries is duly
qualified to conduct business and is in good standing as a foreign corporation or other entity in each jurisdiction in which the
nature of the business conducted or property owned by it makes such qualification necessary, except where the failure to be so
qualified or in good standing, as the case may be, could not have or reasonably be expected to result in a Material Adverse Effect
and no proceeding has been instituted in any such jurisdiction revoking, limiting or curtailing or seeking to revoke, limit or
curtail such power and authority or qualification. The Company has no Subsidiaries except as set forth in the Company’s Annual
Report on Form 10-K for the year ended July 31, 2019.

 

 

 

    	 	12	 

     

    

 

(b)       Authorization;
Enforcement; Validity. (i) The Company has the requisite corporate power and authority to enter into and perform its obligations
under this Agreement, the Registration Rights Agreement and each of the other Transaction Documents to which it is a party, and
to issue the Securities in accordance with the terms hereof and thereof, (ii) the execution and delivery of the Transaction Documents
by the Company and the consummation by it of the transactions contemplated hereby and thereby, including without limitation, the
issuance of the Commitment Shares (as defined below in Section 5(e)) and the reservation for issuance and the issuance of
the Purchase Shares issuable under this Agreement, have been duly authorized by the Company's Board of Directors and no further
consent or authorization is required by the Company, its Board of Directors or its stockholders (except as provided in this Agreement),
(iii) each of this Agreement and the Registration Rights Agreement has been, and each other Transaction Document shall be on the
Commencement Date, duly executed and delivered by the Company and (iv) each of this Agreement and the Registration Rights Agreement
constitutes, and each other Transaction Document upon its execution on behalf of the Company, shall constitute, the valid and binding
obligations of the Company enforceable against the Company in accordance with their terms, except as such enforceability may be
limited by general principles of equity or applicable bankruptcy, insolvency, reorganization, moratorium, liquidation or similar
laws relating to, or affecting generally, the enforcement of creditors' rights and remedies. The Board of Directors of the Company
has approved the resolutions (the “Signing Resolutions”) substantially in the form as set forth as Exhibit
C attached hereto to authorize this Agreement, the Registration Rights Agreement and the transactions contemplated hereby.
The Signing Resolutions are valid, in full force and effect and have not been modified or supplemented in any respect. The Company
has delivered to the Investor a true and correct copy of minutes of a meeting of the Board of Directors of the Company at which
the Signing Resolutions were duly adopted by the Board of Directors or a unanimous written consent adopting the Signing Resolutions
executed by all of the members of the Board of Directors of the Company. Except as set forth in this Agreement, no other approvals
or consents of the Company’s Board of Directors, any authorized committee thereof, or stockholders (except as provided in
this Agreement) is necessary under applicable laws and the Company’s Articles of Incorporation or Bylaws to authorize the
execution and delivery of the Transaction Documents or any of the transactions contemplated thereby, including, but not limited
to, the issuance of the Securities.

 

(c)       Capitalization.
As of the date hereof, the authorized capital stock of the Company is set forth in the Company’s Quarterly Report on Form
10-Q for the quarterly period ended April 30, 2020. Except as disclosed in the SEC Documents (as defined below), (i) no shares
of the Company's capital stock are subject to preemptive rights or any other similar rights or any liens or encumbrances suffered
or permitted by the Company, (ii) there are no outstanding debt securities, (iii) there are no outstanding options, warrants, scrip,
rights to subscribe to, calls or commitments of any character whatsoever relating to, or securities or rights convertible into,
any shares of capital stock of the Company or any of its Subsidiaries, or contracts, commitments, understandings or arrangements
by which the Company or any of its Subsidiaries is or may become bound to issue additional shares of capital stock of the Company
or any of its Subsidiaries or options, warrants, scrip, rights to subscribe to, calls or commitments of any character whatsoever
relating to, or securities or rights convertible into, any shares of capital stock of the Company or any of its Subsidiaries, (iv)
there are no agreements or arrangements under which the Company or any of its Subsidiaries is obligated to register the sale of
any of their securities under the Securities Act (except the Registration Rights Agreement), (v) there are no outstanding securities
or instruments of the Company or any of its Subsidiaries which contain any redemption or similar provisions, and there are no contracts,
commitments, understandings or arrangements by which the Company or any of its Subsidiaries is or may become bound to redeem a
security of the Company or any of its Subsidiaries, (vi) there are no securities or instruments containing anti-dilution or similar
provisions that will be triggered by the issuance of the Securities as described in this Agreement and (vii) the Company does not
have any stock appreciation rights or "phantom stock" plans or agreements or any similar plan or agreement. The Company
has furnished to the Investor true and correct copies of the Company's Articles of Incorporation, as amended and as in effect on
the date hereof (the "Articles of Incorporation"), and the Company's Bylaws, as amended and as in effect on the
date hereof (the "Bylaws"), and summaries of the material terms of all securities convertible into or exercisable
for Common Stock, if any, and copies of any documents containing the material rights of the holders thereof in respect thereto
that are not disclosed in the SEC Documents.

 

 

 

    	 	13	 

     

    

 

(d)       Issuance
of Securities. Upon issuance and payment therefor in accordance with the terms and conditions of this Agreement, the Purchase
Shares (including, without limitation, the Initial Purchase Shares) shall be validly issued, fully paid and nonassessable and free
from all taxes, liens, charges, restrictions (other than such restrictions on transfer arising under the Securities Act prior to
the effective date of the Registration Statement registering the resale thereof by the Investor under the Securities Act), rights
of first refusal and preemptive rights with respect to the issue thereof, with the holders being entitled to all rights accorded
to a holder of Common Stock under the Articles of Incorporation, Bylaws and the Nevada Revised Statutes. Upon issuance in accordance
with the terms and conditions of this Agreement, the Commitment Shares (as defined below in Section 5(e)) shall be validly
issued, fully paid and nonassessable and free from all taxes, liens, charges, restrictions (other than such restrictions on transfer
arising under the Securities Act prior to the effective date of the Registration Statement registering the resale thereof by the
Investor under the Securities Act), rights of first refusal and preemptive rights with respect to the issue thereof, with the holders
being entitled to all rights accorded to a holder of Common Stock under the Articles of Incorporation, Bylaws and the Nevada Revised
Statutes. 20,000,000 shares of Common Stock have been duly authorized and reserved for issuance upon purchase under this Agreement
as Purchase Shares (other than the Initial Purchase Shares).

 

(e)       No
Conflicts. The execution, delivery and performance of the Transaction Documents by the Company and the consummation by the
Company of the transactions contemplated hereby and thereby (including, without limitation, the issuance of the Commitment Shares
and the reservation for issuance and issuance of the Purchase Shares) will not (i) result in a violation of the Articles of Incorporation,
any Certificate of Designations, Preferences and Rights of any outstanding series of preferred stock of the Company or the Bylaws
or (ii) conflict with, or constitute a default (or an event which with notice or lapse of time or both would become a default)
under, or give to others any rights of termination, amendment, acceleration or cancellation of, any agreement, indenture or instrument
to which the Company or any of its Subsidiaries is a party, or result in a violation of any law, rule, regulation, order, judgment
or decree (including federal and state securities laws and regulations and the rules and regulations of the Principal Market applicable
to the Company or any of its Subsidiaries) or by which any property or asset of the Company or any of its Subsidiaries is bound
or affected, except in the case of conflicts, defaults, terminations, amendments, accelerations, cancellations and violations under
clause (ii), which could not reasonably be expected to result in a Material Adverse Effect. Neither the Company nor its Subsidiaries
is in violation of any term of or in default under its articles or certificate of incorporation, any Certificate of Designation,
Preferences and Rights of any outstanding series of preferred stock of the Company or bylaws or their organizational charter or
bylaws, respectively. Neither the Company nor any of its Subsidiaries is in violation of any term of or is in default under any
material contract, agreement, mortgage, indebtedness, indenture, instrument, judgment, decree or order or any statute, rule or
regulation applicable to the Company or its Subsidiaries, except for possible conflicts, defaults, terminations or amendments that
could not reasonably be expected to have a Material Adverse Effect. The business of the Company and its Subsidiaries is not being
conducted, and shall not be conducted, in violation of any law, ordinance or regulation of any governmental entity, except for
possible violations, the sanctions for which either individually or in the aggregate could not reasonably be expected to have a
Material Adverse Effect. Except as specifically contemplated by this Agreement and as required under the Securities Act or applicable
state securities laws and the rules and regulations of the Principal Market, the Company is not required to obtain any consent,
authorization or order of, or make any filing or registration with, any court or governmental agency or any regulatory or self-regulatory
agency in order for it to execute, deliver or perform any of its obligations under or contemplated by the Transaction Documents
in accordance with the terms hereof or thereof. Except as set forth elsewhere in this Agreement, all consents, authorizations,
orders, filings and registrations which the Company is required to obtain pursuant to the preceding sentence shall be obtained
or effected on or prior to the Commencement Date.

 

 

 

    	 	14	 

     

    

 

(f)       SEC
Documents; Financial Statements. The Company has filed with the SEC all reports, schedules, forms, statements and other documents
required to be filed by the Company under the Securities Act and the Exchange Act, including pursuant to Section 13(a) or 15(d)
thereof, for the twelve months preceding the date hereof (or such shorter period as the Company was required by law or regulation
to file such material) (the foregoing materials, including the exhibits thereto and documents incorporated by reference therein,
being collectively referred to herein as the “SEC Documents”).  As of their respective dates, the
SEC Documents complied in all material respects with the requirements of the Securities Act and the Exchange Act, as applicable.
None of the SEC Documents, when filed, contained any untrue statement of a material fact or omitted to state a material fact required
to be stated therein or necessary in order to make the statements therein, in the light of the circumstances under which they were
made, not misleading. The financial statements of the Company included in the SEC Documents comply in all material respects with
applicable accounting requirements and the rules and regulations of the SEC with respect thereto as in effect at the time of filing.  Such
financial statements have been prepared in accordance with United States generally accepted accounting principles applied on a
consistent basis during the periods involved (“GAAP”), except as may be otherwise specified in such financial
statements or the notes thereto and except that unaudited financial statements may not contain all footnotes required by GAAP,
and fairly present in all material respects the financial position of the Company and its consolidated Subsidiaries as of and for
the dates thereof and the results of operations and cash flows for the periods then ended, subject, in the case of unaudited statements,
to normal, immaterial, year-end audit adjustments. Except as set forth in the SEC Documents, the Company has received no notices
or correspondence from the SEC for the one year preceding the date hereof. The SEC has not commenced any enforcement proceedings
against the Company or any of its Subsidiaries.

 

(g)       Absence
of Certain Changes. Except as disclosed in the SEC Documents, since July 31, 2019, there has been no material adverse change
in the business, properties, operations, financial condition or results of operations of the Company or its Subsidiaries. The Company
has not taken any steps, and does not currently expect to take any steps, to seek protection pursuant to any Bankruptcy Law nor
does the Company or any of its Subsidiaries have any knowledge or reason to believe that its creditors intend to initiate involuntary
bankruptcy or insolvency proceedings. The Company is financially solvent and is generally able to pay its debts as they become
due.

 

(h)       Absence
of Litigation. There is no action, suit, proceeding, inquiry or investigation before or by any court, public board, government
agency, self-regulatory organization or body pending or, to the knowledge of the Company or any of its Subsidiaries, threatened
against or affecting the Company, the Common Stock or any of the Company's or its Subsidiaries' officers or directors in their
capacities as such, which could reasonably be expected to have a Material Adverse Effect.

 

(i)       Acknowledgment
Regarding Investor's Status. The Company acknowledges and agrees that the Investor is acting solely in the capacity of arm's
length purchaser with respect to the Transaction Documents and the transactions contemplated hereby and thereby. The Company further
acknowledges that the Investor is not acting as a financial advisor or fiduciary of the Company (or in any similar capacity) with
respect to the Transaction Documents and the transactions contemplated hereby and thereby and any advice given by the Investor
or any of its representatives or agents in connection with the Transaction Documents and the transactions contemplated hereby and
thereby is merely incidental to the Investor's purchase of the Securities. The Company further represents to the Investor that
the Company's decision to enter into the Transaction Documents has been based solely on the independent evaluation by the Company
and its representatives and advisors.

 

 

 

    	 	15	 

     

    

 

(j)       No
General Solicitation; No Integrated Offering. Neither the Company, nor any of its affiliates, nor any Person acting on its
or their behalf, has engaged in any form of general solicitation or general advertising (within the meaning of Regulation D under
the Securities Act) in connection with the offer or sale of the Securities. Neither the Company, nor or any of its affiliates,
nor any Person acting on their behalf has, directly or indirectly, made any offers or sales of any security or solicited any offers
to buy any security, under circumstances that would require registration of the offer and sale of any of the Securities under the
Securities Act, whether through integration with prior offerings or otherwise, or cause this offering of the Securities to be integrated
with prior offerings by the Company in a manner that would require stockholder approval pursuant to the rules of the Principal
Market on which any of the securities of the Company are listed or designated. The issuance and sale of the Securities hereunder
does not contravene the rules and regulations of the Principal Market.

 

(k)       Intellectual
Property Rights. The Company and its Subsidiaries own or possess adequate rights or licenses to use all material trademarks,
trade names, service marks, service mark registrations, service names, patents, patent rights, copyrights, inventions, licenses,
approvals, governmental authorizations, trade secrets and rights necessary to conduct their respective businesses as now conducted.
None of the Company's material trademarks, trade names, service marks, service mark registrations, service names, patents, patent
rights, copyrights, inventions, licenses, approvals, government authorizations, trade secrets or other intellectual property rights
have expired or terminated, or, by the terms and conditions thereof, could expire or terminate within two years from the date of
this Agreement. The Company and its Subsidiaries do not have any knowledge of any infringement by the Company or its Subsidiaries
of any material trademark, trade name rights, patents, patent rights, copyrights, inventions, licenses, service names, service
marks, service mark registrations, trade secret or other similar rights of others, or of any such development of similar or identical
trade secrets or technical information by others, and there is no claim, action or proceeding being made or brought against, or
to the Company's knowledge, being threatened against, the Company or its Subsidiaries regarding trademark, trade name, patents,
patent rights, invention, copyright, license, service names, service marks, service mark registrations, trade secret or other infringement,
which could reasonably be expected to have a Material Adverse Effect.

 

(l)       Environmental
Laws. The Company and its Subsidiaries (i) are in compliance with any and all applicable foreign, federal, state and local
laws and regulations relating to the protection of human health and safety, the environment or hazardous or toxic substances or
wastes, pollutants or contaminants (“Environmental Laws”), (ii) have received all permits, licenses or other
approvals required of them under applicable Environmental Laws to conduct their respective businesses and (iii) are in compliance
with all terms and conditions of any such permit, license or approval, except where, in each of the three foregoing clauses, the
failure to so comply could not reasonably be expected to have, individually or in the aggregate, a Material Adverse Effect.

 

(m)       Title.
The Company and its Subsidiaries have good and marketable title in fee simple to all real property owned by them and good and marketable
title in all personal property owned by them that is material to the business of the Company and its Subsidiaries, in each case
free and clear of all liens, encumbrances and defects (“Liens”) and, except for Liens as do not materially affect
the value of such property and do not materially interfere with the use made and proposed to be made of such property by the Company
and its Subsidiaries and Liens for the payment of federal, state or other taxes, the payment of which is neither delinquent nor
subject to penalties.  Any real property and facilities held under lease by the Company and its Subsidiaries are held
by them under valid, subsisting and enforceable leases with which the Company and its Subsidiaries are in compliance with such
exceptions as are not material and do not interfere with the use made and proposed to be made of such property and buildings by
the Company and its Subsidiaries.

 

(n)       Regulatory
Permits. The Company and its Subsidiaries possess all material certificates, authorizations and permits issued by the appropriate
federal, state or foreign regulatory authorities necessary to conduct their respective businesses, and neither the Company nor
any such Subsidiary has received any notice of proceedings relating to the revocation or modification of any such certificate,
authorization or permit.

 

 

 

    	 	16	 

     

    

 

(o)       Tax
Status. The Company and each of its Subsidiaries has made or filed all federal and state income and all other material tax
returns, reports and declarations required by any jurisdiction to which it is subject (unless and only to the extent that the Company
and each of its Subsidiaries has set aside on its books provisions reasonably adequate for the payment of all unpaid and unreported
taxes) and has paid all taxes and other governmental assessments and charges that are material in amount, shown or determined to
be due on such returns, reports and declarations, except those being contested in good faith and has set aside on its books provision
reasonably adequate for the payment of all taxes for periods subsequent to the periods to which such returns, reports or declarations
apply. There are no unpaid taxes in any material amount claimed to be due by the taxing authority of any jurisdiction, and the
officers of the Company know of no basis for any such claim.

 

(p)       Transactions
With Affiliates.  Except as set forth
in the SEC Documents, none of the officers or directors of the Company and, to the knowledge of the Company, none of the employees
of the Company is presently a party to any transaction with the Company or any Subsidiary (other than for services as employees,
officers and directors), including any contract, agreement or other arrangement providing for the furnishing of services to or
by, providing for rental of real or personal property to or from, or otherwise requiring payments to or from any officer, director
or such employee or, to the knowledge of the Company, any entity in which any officer, director, or any such employee has a substantial
interest or is an officer, director, trustee or partner, in each case in excess of $120,000 other than for (i) payment of salary
or consulting fees for services rendered, (ii) reimbursement for expenses incurred on behalf of the Company and (iii) other employee
benefits, including stock option agreements under any stock option plan of the Company.

 

(q)       Application
of Takeover Protections. The Company and its board of directors have taken or will take prior to the Commencement Date all
necessary action, if any, in order to render inapplicable any control share acquisition, business combination, poison pill (including
any distribution under a rights agreement) or other similar anti-takeover provision under the Articles of Incorporation or the
laws of the state of its incorporation which is or could become applicable to the Investor as a result of the transactions contemplated
by this Agreement, including, without limitation, the Company's issuance of the Securities and the Investor's ownership of the
Securities.

 

(r)        Disclosure.  Except
with respect to the material terms and conditions of the transactions contemplated by the Transaction Documents that will be timely
publicly disclosed by the Company, the Company confirms that neither it nor any other Person acting on its behalf has provided
the Investor or its agents or counsel with any information that it believes constitutes or might constitute material, non-public
information which is not otherwise disclosed in the Registration Statement or the SEC Documents.   The Company understands
and confirms that the Investor will rely on the foregoing representation in effecting purchases and sales of securities of the
Company.  All of the disclosure furnished by or on behalf of the Company to the Investor regarding the Company, its business
and the transactions contemplated hereby, including the disclosure schedules to this Agreement, is true and correct and does not
contain any untrue statement of a material fact or omit to state any material fact necessary in order to make the statements made
therein, in light of the circumstances under which they were made, not misleading. The press releases disseminated by the Company
during the twelve months preceding the date of this Agreement are true and correct in all material respects.  The Company
acknowledges and agrees that the Investor neither makes nor has made any representations or warranties with respect to the transactions
contemplated hereby other than those specifically set forth in Section 3 hereof.

 

(s)       Foreign
Corrupt Practices.  Neither the Company,
nor to the knowledge of the Company, any agent or other Person acting on behalf of the Company, has (i) directly or indirectly,
used any funds for unlawful contributions, gifts, entertainment or other unlawful expenses related to foreign or domestic political
activity, (ii) made any unlawful payment to foreign or domestic government officials or employees or to any foreign or domestic
political parties or campaigns from corporate funds, (iii) failed to disclose fully any contribution made by the Company (or made
by any Person acting on its behalf of which the Company is aware) which is in violation of law, or (iv) violated in any material
respect any provision of the Foreign Corrupt Practices Act of 1977, as amended.

 

 

 

    	 	17	 

     

    

 

(t)       DTC
Eligibility. The Company, through the Transfer Agent, currently participates in the DTC Fast Automated Securities Transfer
(FAST) Program and the Common Stock can be transferred electronically to third parties via the DTC Fast Automated Securities Transfer
(FAST) Program.

 

(u)       Sarbanes-Oxley.
The Company is in compliance in all material respects with all provisions of the Sarbanes-Oxley Act of 2002, as amended, which
are applicable to it as of the date hereof.

 

(v)       Certain
Fees. Except as set forth in Schedule 4(v), no brokerage or finder’s fees or commissions are or will be payable
by the Company to any broker, financial advisor or consultant, finder, placement agent, investment banker, bank or other Person
with respect to the transactions contemplated by the Transaction Documents. The Investor shall have no obligation with respect
to any fees or with respect to any claims made by or on behalf of other Persons for fees of a type contemplated in this Section
4(v) that may be due in connection with the transactions contemplated by the Transaction Documents.

 

(w)       Investment
Company. The Company is not, and immediately after receipt of payment for the Securities will not be, an “investment
company” within the meaning of the Investment Company Act of 1940, as amended.

 

(x)       Listing
and Maintenance Requirements. The Common Stock is registered pursuant to Section 12(g) of the Exchange Act, and the Company
has taken no action designed to, or which to its knowledge is likely to have the effect of, terminating the registration of the
Common Stock pursuant to the Exchange Act nor has the Company received any notification that the SEC is currently contemplating
terminating such registration. The Company has not, in the twelve (12) months preceding the date hereof, received any notice from
any Person to the effect that the Company is not in compliance with the listing or maintenance requirements of the Principal Market.
The Company is, and has no reason to believe that it will not in the foreseeable future continue to be, in compliance with all
such listing and maintenance requirements. The Principal Market has not commenced any delisting proceedings against the Company.

 

(y)       Accountants.
The Company’s accountants are set forth in the SEC Documents and, to the knowledge of the Company, such accountants are an
independent registered public accounting firm as required by the Securities Act.

 

(z)       No
Market Manipulation. The Company has not, and to its knowledge no Person acting on its behalf has, (i) taken, directly
or indirectly, any action designed to cause or to result in the stabilization or manipulation of the price of any security of the
Company to facilitate the sale or resale of any of the Securities, (ii) sold, bid for, purchased, or, paid any compensation
for soliciting purchases of, any of the Securities, or (iii) paid or agreed to pay to any Person any compensation for soliciting
another to purchase any other securities of the Company.

 

(aa)Shell Company
Status. The Company is not currently, and has never been, an issuer identified in Rule 144(i)(1) under the Securities Act.

 

(bb)No Disqualification
Events. None of the Company, any of its predecessors, any affiliated issuer, any director, executive officer, other officer
of the Company participating in the offering contemplated hereby, any beneficial owner of 20% or more of the Company's outstanding
voting equity securities, calculated on the basis of voting power, nor any promoter (as that term is defined in Rule 405 under
the Securities Act) connected with the Company in any capacity at the time of sale (each, an “Issuer Covered Person”)
is subject to any of the “Bad Actor” disqualifications described in Rule 506(d)(1)(i) to (viii) under the Securities
Act (a “Disqualification Event”), except for a Disqualification Event covered by Rule 506(d)(2) or (d)(3) under
the Securities Act. The Company has exercised reasonable care to determine whether any Issuer Covered Person is subject to a Disqualification
Event.

 

 

 

    	 	18	 

     

    

 

5.       COVENANTS.

 

(a)       Filing
of Current Report and Registration Statement. The Company agrees that it shall, within the time required under the Exchange
Act, file with the SEC a Current Report on Form 8-K relating to the transactions contemplated by, and describing the material terms
and conditions of, the Transaction Documents (the “Current Report”). The Company shall permit the Investor to
review and comment upon the substantially final pre-filing draft version of the Current Report at least two (2) Business Days prior
to its filing with the SEC, and the Company shall give due consideration to all such comments. The Investor shall use its reasonable
best efforts to comment upon the substantially final pre-filing draft version of the Current Report within one (1) Business Day
from the date the Investor receives it from the Company. The Company shall also file with the SEC, within twenty (20) Business
Days from the date hereof, a new registration statement (the “Registration Statement”) covering only the resale
of the Purchase Shares (including, without limitation, all of the Initial Purchase Shares) and all of the Commitment Shares, in
accordance with the terms of the Registration Rights Agreement between the Company and the Investor, dated as of the date hereof
(the “Registration Rights Agreement”).

 

(b)       Blue
Sky. The Company shall take all such action, if any, as is reasonably necessary in order to obtain an exemption for or to register
or qualify (i) the issuance of the Commitment Shares and the sale of the Purchase Shares to the Investor under this Agreement and
(ii) any subsequent resale of all Commitment Shares and all Purchase Shares by the Investor, in each case, under applicable securities
or “Blue Sky” laws of the states of the United States in such states as is reasonably requested by the Investor from
time to time, and shall provide evidence of any such action so taken to the Investor.

 

(c)       Listing/DTC.
The Company shall promptly secure the listing of all of the Purchase Shares and Commitment Shares to be issued to the Investor
hereunder on the Principal Market (subject to official notice of issuance) and upon each other national securities exchange or
automated quotation system, if any, upon which the Common Stock is then listed, and shall use commercially reasonable efforts to
maintain, so long as any shares of Common Stock shall be so listed, such listing of all such Securities from time to time issuable
hereunder. The Company shall maintain the listing of the Common Stock on the Principal Market and shall comply with the Company’s
reporting, filing and other obligations under the bylaws or rules and regulations of the Principal Market. Neither the Company
nor any of its Subsidiaries shall take any action that would reasonably be expected to result in the delisting or suspension of
the Common Stock on the Principal Market. The Company shall promptly, and in no event later than the Business Day immediately following
the date of receipt by the Company, provide to the Investor copies of any notices it receives from the Principal Market regarding
the continued eligibility of the Common Stock for listing on the Principal Market; provided, however, that the Company shall not
be required to provide the Investor copies of any such notice that the Company (i) reasonably believes constitutes material non-public
information or (ii) is not be required to be publicly disclosed in any report or statement filed with the SEC under the Exchange
Act or the Securities Act. The Company shall pay all fees and expenses in connection with satisfying its obligations under this
Section 5(c). The Company shall take all action necessary to ensure that its Common Stock can be transferred electronically
as DWAC Shares.

 

(d)       Prohibition
of Short Sales and Hedging Transactions. The Investor agrees that beginning on the date of this Agreement and ending on the
date of termination of this Agreement as provided in Section 11, the Investor and its agents, representatives and affiliates shall
not in any manner whatsoever enter into or effect, directly or indirectly, any (i) “short sale” (as such term is defined
in Rule 200 of Regulation SHO of the Exchange Act) of the Common Stock or (ii) hedging transaction, which establishes a net short
position with respect to the Common Stock.

 

(e)       Issuance
of Commitment Shares. In consideration for the Investor’s execution and delivery of this Agreement, the Company shall
cause to be issued to the Investor a total of 793,802 shares of Common Stock (the “Commitment Shares”) not later
than the close of business on the next Business Day immediately following the date of this Agreement and shall, concurrently with
the execution of this Agreement on the date hereof, deliver to the Transfer Agent the Irrevocable Transfer Agent Instructions with
respect to the issuance of such Commitment Shares to the Investor within such time period. For the avoidance of doubt, all of the
Commitment Shares shall be fully earned as of the date of this Agreement, whether or not the Commencement shall occur or any Purchase
Shares (other than the Initial Purchase Shares) are purchased by the Investor under this Agreement and irrespective of any subsequent
termination of this Agreement.

 

 

 

    	 	19	 

     

    

 

(f)       Due
Diligence; Non-Public Information. The Investor shall have the right, from time to time as the Investor may reasonably deem
appropriate, to perform reasonable due diligence on the Company during normal business hours. Subject to the below restrictions
and covenants regarding material, non-public information, the Company and its officers and employees shall provide information
and reasonably cooperate with the Investor in connection with any reasonable request by the Investor related to the Investor's
due diligence of the Company. Each party hereto agrees not to disclose any Confidential Information of the other party to any third
party and shall not use the Confidential Information for any purpose other than in connection with, or in furtherance of, the transactions
contemplated hereby. Each party hereto acknowledges that the Confidential Information shall remain the property of the disclosing
party and agrees that it shall take all reasonable measures to protect the secrecy of any Confidential Information disclosed by
the other party. The Company confirms that neither it, nor or any of its Subsidiaries or affiliates will, and the Company shall
use its reasonable best efforts to ensure that none of their respective directors, officers, employees, stockholders, agents or
other Persons acting on their behalf will, directly or indirectly, provide the Investor or its agents or counsel with any information
that constitutes or might constitute material, non-public information, unless a simultaneous public announcement thereof is made
by the Company in the manner contemplated by Regulation FD. In the event of a breach of the foregoing covenant by the Company,
any of its Subsidiaries or affiliates, or any of their respective directors, officers, employees, stockholders, agents or other
Persons acting on their behalf (as determined in the reasonable good faith judgment of the Investor), in addition to any other
remedy provided herein or in the other Transaction Documents, the Investor shall have the right to make a public disclosure, in
the form of a press release, public advertisement or otherwise, of such material, non-public information without the prior approval
by the Company; provided the Investor shall have first provided notice to the Company that it believes it has received information
that constitutes material, non-public information, the Company shall have at least 24 hours to publicly disclose such material,
non-public information prior to any such disclosure by the Investor, and the Company shall have failed to publicly disclose such
material, non-public information within such time period. The Investor shall not have any liability to the Company, any of its
Subsidiaries or affiliates, or any of their respective directors, officers, employees, stockholders, agents or other Persons acting
on their behalf, for any such disclosure. The Company understands and confirms that the Investor shall be relying on the foregoing
covenants in effecting transactions in securities of the Company.

 

(g)        Purchase
Records. The Investor and the Company shall each maintain records showing the remaining Available Amount at any given time
and the dates and Purchase Amounts for each Regular Purchase, Accelerated Purchase and Additional Accelerated Purchase and the
Initial Purchase or shall use such other method, reasonably satisfactory to the Investor and the Company.

 

(h)
       Taxes. The Company
shall pay any and all transfer, stamp or similar taxes that may be payable with respect to the issuance and delivery of any shares
of Common Stock to the Investor made under this Agreement.

 

(i)       Use
of Proceeds. The Company will use the net proceeds from the offering as described in the Registration Statement or the SEC
Documents.

 

(j)       Other
Transactions. During the term of this Agreement, the Company shall not enter into, announce or recommend to its shareholders
any agreement, plan, arrangement or transaction in or of which the terms thereof would restrict, materially delay, conflict with
or impair the ability or right of the Company to perform its obligations under the Transaction Documents, including, without limitation,
the obligation of the Company to deliver the Purchase Shares and the Commitment Shares to the Investor in accordance with the terms
of the Transaction Documents.

 

 

 

    	 	20	 

     

    

 

(k)       Integration.
From and after the date of this Agreement, neither the Company, nor or any of its affiliates will, and the Company shall use its
reasonable best efforts to ensure that no Person acting on their behalf will, directly or indirectly, make any offers or sales
of any security or solicit any offers to buy any security, under circumstances that would (i) require registration of the offer
and sale by the Company to the Investor of any of the Securities under the Securities Act, or (ii) cause this offering of the Securities
by the Company to the Investor to be integrated with other offerings by the Company in a manner that would require stockholder
approval pursuant to the rules of the Principal Market on which any of the securities of the Company are listed or designated,
unless in the case of this clause (ii), stockholder approval is obtained before the closing of such subsequent transaction in accordance
with the rules of such Principal Market.

 

(l)       Limitation
on Variable Rate Transactions. From and after the date of this Agreement until the later of (i) the 36-month anniversary of
the date of this Agreement and (ii) the 36-month anniversary of the Commencement Date (if the Commencement has occurred), in either
case irrespective of any earlier termination of this Agreement, the Company shall be prohibited from effecting or entering into
an agreement to effect any issuance by the Company or any of its Subsidiaries of Common Stock or Common Stock Equivalents (or a
combination of units thereof) involving a Variable Rate Transaction, other than in connection with an Exempt Issuance. The Investor
shall be entitled to obtain injunctive relief against the Company and its Subsidiaries to preclude any such issuance, which remedy
shall be in addition to any right to collect damages, without the necessity of showing economic loss and without any bond or other
security being required. “Common Stock Equivalents” means any securities of the Company or its Subsidiaries
which entitle the holder thereof to acquire at any time Common Stock, including, without limitation, any debt, preferred stock,
rights, options, warrants or other instrument that is at any time convertible into or exercisable or exchangeable for, or otherwise
entitles the holder thereof to receive, Common Stock. “Variable Rate Transaction” means a transaction in which
the Company (i) issues or sells any debt or equity securities that are convertible into, exchangeable or exercisable for, or include
the right to receive additional shares of Common Stock or Common Stock Equivalents either (A) at a conversion price, exercise price,
exchange rate or other price that is based upon and/or varies with the trading prices of or quotations for the Common Stock at
any time after the initial issuance of such debt or equity securities (including, without limitation, pursuant to any “cashless
exercise” provision), or (B) with a conversion, exercise or exchange price that is subject to being reset at some future
date after the initial issuance of such debt or equity security or upon the occurrence of specified or contingent events directly
or indirectly related to the business of the Company or the market for the Common Stock (including, without limitation, any “full
ratchet” or “weighted average” anti-dilution provisions), (ii) issues or sells any debt or equity securities,
including without limitation, Common Stock or Common Stock Equivalents, either (A) at a price that is subject to being reset at
some future date after the initial issuance of such debt or equity security or upon the occurrence of specified or contingent events
directly or indirectly related to the business of the Company or the market for the Common Stock, or (B) that is subject to or
contains any put, call, redemption, buy-back, price-reset or other similar provision or mechanism (including, without limitation,
a “Black-Scholes” put or call right) that provides for the issuance of additional debt or equity securities of the
Company or the payment of cash by the Company, or (iii) enters into any agreement, including, but not limited to, an “equity
line of credit”, “at-the-market offering” or other continuous offering or similar offering of Common Stock or
Common Stock Equivalents, whereby the Company may sell Common Stock or Common Stock Equivalents at a future determined price. “Exempt
Issuance” means the issuance of (a) Common Stock, options or other equity incentive awards to employees, officers, directors
or vendors of the Company pursuant to any equity incentive plan duly adopted (before or after the date of this Agreement) for such
purpose by the Board of Directors or a majority of the members of a committee of directors established for such purpose, (b) (1)
any Securities issued to the Investor pursuant to this Agreement, (2) any securities issued upon the exercise or exchange of or
conversion of any shares of Common Stock or Common Stock Equivalents held by the Investor at any time, or (3) any securities issued
upon the exercise or exchange of or conversion of any Common Stock Equivalents issued and outstanding on the date of this Agreement,
provided that such securities referred to in this clause (3) have not been amended since the date of this Agreement to increase
the number of such securities or to decrease the exercise price, exchange price or conversion price of such securities, (c) securities
issued pursuant to acquisitions, divestitures, licenses, partnerships, collaborations or strategic transactions approved by the
Board of Directors or a majority of the members of a committee of directors established for such purpose, which acquisitions, divestitures,
licenses, partnerships, collaborations or strategic transactions can have a Variable Rate Transaction component, provided that
any such issuance shall only be to a Person (or to the equity holders of a Person) which is, itself or through its subsidiaries,
an operating company or an asset in a business synergistic with the business of the Company and shall provide to the Company additional
benefits in addition to the investment of funds, but shall not include a transaction in which the Company is issuing securities
primarily for the purpose of raising capital or to an entity whose primary business is investing in securities, or (d) Common Stock
issued pursuant to an “at-the-market offering” by the Company exclusively through one or more registered broker-dealers
acting primarily as agent(s) of the Company pursuant to a written equity distribution or sales agreement between the Company and
such registered broker-dealer(s).

 

 

 

    	 	21	 

     

    

 

6.       TRANSFER
AGENT INSTRUCTIONS.

 

 

(b)              
 On the date of this Agreement, the Company shall issue irrevocable instructions to the Transfer Agent substantially in
the form attached hereto as Exhibit C to issue the Initial Purchase Shares and the Commitment Shares in accordance
with the terms of this Agreement (the “Irrevocable Transfer Agent Instructions”). The certificate(s) or book-entry
statement(s) representing the Initial Purchase Shares and the Commitment Shares, except as set forth below, shall bear the following
restrictive legend (the “Restrictive Legend”):

 

THE SECURITIES REPRESENTED BY
THIS CERTIFICATE HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR APPLICABLE STATE SECURITIES LAWS. THE
SECURITIES HAVE BEEN ACQUIRED FOR INVESTMENT AND MAY NOT BE OFFERED FOR SALE, SOLD, TRANSFERRED OR ASSIGNED IN THE ABSENCE OF AN
EFFECTIVE REGISTRATION STATEMENT FOR THE SECURITIES UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR APPLICABLE STATE SECURITIES
LAWS, UNLESS SOLD PURSUANT TO: (1) RULE 144 UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR (2) AN OPINION OF HOLDER’S COUNSEL,
IN A CUSTOMARY FORM, THAT REGISTRATION IS NOT REQUIRED UNDER SAID ACT OR APPLICABLE STATE SECURITIES LAWS.

 

(c)              
On the earlier of (i) the Commencement Date and (ii) such time that the Investor shall request, provided all conditions
of Rule 144 under the Securities Act are met (and, if reasonably requested by the Company or the Transfer Agent, delivery by the
Investor of an executed Rule 144 seller representation letter in customary form and substance), the Company shall, no later than
two (2) Business Days following the delivery by the Investor to the Company or the Transfer Agent of one or more legended certificates
or book-entry statements representing the Initial Purchase Shares and/or Commitment Shares (which certificates or book-entry statements
the Investor shall promptly deliver on or prior to the first to occur of the events described in clauses (i) and (ii) of this sentence),
as directed by the Investor, issue and deliver (or cause to be issued and delivered) to the Investor, as requested by the Investor,
either: (A) a certificate or book-entry statement representing such Initial Purchase Shares and/or Commitment Shares that is free
from all restrictive and other legends or (B) a number of shares of Common Stock equal to the number of Initial Purchase Shares
and/or Commitment Shares represented by the certificate(s) or book-entry statement(s) so delivered by the Investor as DWAC Shares.
The Company shall take all actions necessary or desirable to carry out the intent and accomplish the purposes of the immediately
preceding sentence, including, without limitation, delivering all such legal opinions, consents, certificates, resolutions and
instructions to the Transfer Agent, and any successor transfer agent of the Company, as may be requested from time to time by the
Investor or necessary or desirable to carry out the intent and accomplish the purposes of the immediately preceding sentence. On
the Commencement Date, the Company shall issue to the Transfer Agent, and any subsequent transfer agent, (i) irrevocable instructions
in the form substantially similar to those used by the Investor in substantially similar transactions (the “Commencement
Irrevocable Transfer Agent Instructions”) and (ii) the notice of effectiveness of the Registration Statement in the form
attached as an exhibit to the Registration Rights Agreement (the “Notice of Effectiveness of Registration Statement”),
in each case to issue the Commitment Shares and the Purchase Shares in accordance with the terms of this Agreement and the Registration
Rights Agreement. All Purchase Shares to be issued from and after Commencement to or for the benefit of the Investor pursuant to
this Agreement shall be issued only as DWAC Shares. The Company represents and warrants to the Investor that, while this Agreement
is effective, no instruction other than the Commencement Irrevocable Transfer Agent Instructions and the Notice of Effectiveness
of Registration Statement referred to in this Section 6(b) will be given by the Company to the Transfer Agent with respect
to the Purchase Shares or the Commitment Shares from and after Commencement, and the Purchase Shares and the Commitment Shares
covered by the Registration Statement shall otherwise be freely transferable on the books and records of the Company. The Company
agrees that if the Company fails to fully comply with the provisions of this Section 6(b) within five (5) Business Days
of the Investor providing the deliveries referred to above, the Company shall, at the Investor’s written instruction, purchase
such shares of Common Stock containing the Restrictive Legend from the Investor at the greater of the (i) purchase price paid for
such shares of Common Stock (as applicable) and (ii) the Closing Sale Price of the Common Stock on the date of the Investor’s
written instruction.

 

 

 

    	 	22	 

     

    

 

		7.	CONDITIONS TO THE COMPANY'S RIGHT TO COMMENCE SALES
OF SHARES OF COMMON STOCK.

 

I.       The
right of the Company hereunder to sell the Initial Purchase Shares on the date of this Agreement is subject to the satisfaction
of each of the following conditions:

 

(a) The Investor
shall have executed each of the Transaction Documents and delivered the same to the Company; and

 

(b) The representations
and warranties of the Investor shall be true and correct in all material respects as of the date hereof.

 

II.        The
right of the Company hereunder to commence sales of the Purchase Shares (other than the Initial Purchase Shares) on the Commencement
Date is subject to the satisfaction of each of the following conditions:

 

(a) The Investor
shall have executed each of the Transaction Documents and delivered the same to the Company;

 

(b) The Registration
Statement covering the resale of the Purchase Shares (including, without limitation, all of the Initial Purchase Shares) and all
of the Commitment Shares shall have been declared effective under the Securities Act by the SEC, and no stop order with respect
to the Registration Statement shall be pending or threatened by the SEC; and 

 

(c) The representations
and warranties of the Investor shall be true and correct in all material respects as of the date hereof and as of the Commencement
Date as though made at that time.

 

		8.	CONDITIONS TO THE INVESTOR'S OBLIGATION TO PURCHASE SHARES OF COMMON STOCK.

 

I.       The
obligation of the Investor to buy the Initial Purchase Shares under this Agreement is subject to the satisfaction of each of the
following conditions:

 

(a)       The
Company shall have executed each of the Transaction Documents and delivered the same to the Investor;

 

(b)       The Common Stock shall be listed or quoted on the Principal Market, trading in the Common Stock shall not have been within
the last 365 days suspended by the SEC or the Principal Market, and all Securities to be issued by the Company to the Investor
pursuant to this Agreement shall have been, if applicable, approved for listing or quotation on the Principal Market in accordance
with the applicable rules and regulations of the Principal Market, subject only to official notice of issuance;

 

(c)        The
representations and warranties of the Company contained in Section 4 shall be true and correct in all material respects
(except to the extent that any of such representations and warranties is already qualified as to materiality in Section 4
above, in which case, such representations and warranties shall be true and correct without further qualification) as of the date
hereof (except for representations and warranties that speak as of a specific date, which shall be true and correct in all material
respects as of such specific date, or to the extent already qualified as to materiality in Section 4 above shall be true
and correct in all respects as of such specific date) and the Company shall have performed, satisfied and complied with the covenants,
agreements and conditions required by the Transaction Documents to be performed, satisfied or complied with by the Company at
or prior to the date hereof. The Investor shall have received a certificate, executed by the Chief Executive Officer (“CEO”),
President or Chief Financial Officer (“CFO”) of the Company, dated as of the date hereof, to the foregoing
effect in the form attached hereto as Exhibit A;

 

 

 

    	 	23	 

     

    

 

(d)       The
Board of Directors of the Company shall have adopted the Signing Resolutions, which shall be in full force and effect without any
amendment or supplement thereto as of the date hereof;

 

(e)       The
Irrevocable Transfer Agent Instructions shall have been delivered by the Company to the Transfer Agent (or any successor transfer
agent) and acknowledged in writing (including by email) by the Transfer Agent (or any successor transfer agent);

 

(f)       All
federal, state and local governmental laws, rules and regulations applicable to the transactions contemplated by the Transaction
Documents and necessary for the execution, delivery and performance of the Transaction Documents and the consummation of the transactions
contemplated thereby in accordance with the terms thereof shall have been complied with, and all consents, authorizations and orders
of, and all filings and registrations with, all federal, state and local courts or governmental agencies and all federal, state
and local regulatory or self-regulatory agencies necessary for the execution, delivery and performance of the Transaction Documents
and the consummation of the transactions contemplated thereby in accordance with the terms thereof shall have been obtained or
made, including, without limitation, in each case those required under the Securities Act, the Exchange Act, applicable state securities
or “Blue Sky” laws or applicable rules and regulations of the Principal Market, or otherwise required by the SEC, the
Principal Market or any state securities regulators;

 

(g)       No
statute, regulation, order, decree, writ, ruling or injunction shall have been enacted, entered, promulgated, threatened or endorsed
by any federal, state or local court or governmental authority of competent jurisdiction which prohibits the consummation of or
which would materially modify or delay any of the transactions contemplated by the Transaction Documents; and

 

(h)       No
action, suit or proceeding before any federal, state, local or foreign arbitrator or any court or governmental authority of competent
jurisdiction shall have been commenced or threatened, and no inquiry or investigation by any federal, state, local or foreign governmental
authority of competent jurisdiction shall have been commenced or threatened, against the Company, or any of the officers, directors
or affiliates of the Company, seeking to restrain, prevent or change the transactions contemplated by the Transaction Documents,
or seeking material damages in connection with such transactions.

 

II.        The
obligation of the Investor to buy Purchase Shares (other than the Initial Purchase Shares) under this Agreement is subject to the
satisfaction of each of the following conditions on or prior to the Commencement Date and, once such conditions have been initially
satisfied, there shall not be any ongoing obligation to satisfy such conditions after the Commencement has occurred:

 

(a)       The
Company shall have executed each of the Transaction Documents and delivered the same to the Investor;

 

(b)       The
Company shall have issued or caused to be issued to the Investor (i) one or more certificates or book-entry statements representing
the Initial Purchase Shares and the Commitment Shares free from all restrictive and other legends or (ii) a number of shares of
Common Stock equal to the number of Initial Purchase Shares and Commitment Shares as DWAC Shares, in each case in accordance with
Section 6(b);

 

(c)       The
Common Stock shall be listed or quoted on the Principal Market, trading in the Common Stock shall not have been within the last
365 days suspended by the SEC or the Principal Market, and all Securities to be issued by the Company to the Investor pursuant
to this Agreement shall have been, if applicable, approved for listing or quotation on the Principal Market in accordance with
the applicable rules and regulations of the Principal Market, subject only to official notice of issuance;

 

 

 

    	 	24	 

     

    

 

(d)       The
Investor shall have received the opinions of the Company's legal counsel dated as of the Commencement Date substantially in the
forms agreed prior to the date of this Agreement by the Company’s legal counsel and the Investor’s legal counsel;

 

(e)       The
representations and warranties of the Company contained in Section 4 shall be true and correct in all material respects
(except to the extent that any of such representations and warranties is already qualified as to materiality in Section 4
above, in which case, such representations and warranties shall be true and correct without further qualification) as of the date
hereof and as of the Commencement Date as though made at that time (except for representations and warranties that speak as of
a specific date, which shall be true and correct in all material respects as of such specific date, or to the extent already qualified
as to materiality in Section 4 above shall be true and correct in all respects as of such specific date) and the Company
shall have performed, satisfied and complied with the covenants, agreements and conditions required by the Transaction Documents
to be performed, satisfied or complied with by the Company at or prior to the Commencement Date. The Investor shall have received
a certificate, executed by the CEO, President or CFO of the Company, dated as of the Commencement Date, to the foregoing effect
in the form attached hereto as Exhibit A;

 

(f)       The
Board of Directors of the Company shall have adopted the Signing Resolutions, which shall be in full force and effect without any
amendment or supplement thereto as of the Commencement Date;

 

(g)       As
of the Commencement Date, the Company shall have reserved out of its authorized and unissued Common Stock, solely for the purpose
of effecting purchases of Purchase Shares (other than the Initial Purchase Shares) hereunder, 20,000,000 shares of Common Stock;

 

(h)       The
Commencement Irrevocable Transfer Agent Instructions and the Notice of Effectiveness of Registration Statement each shall have
been delivered to the Transfer Agent (or any successor transfer agent) and acknowledged in writing (including by email) by the
Transfer Agent (or any successor transfer agent);

 

(i)       The
Company shall have delivered to the Investor a certificate evidencing the incorporation and good standing of the Company in the
State of Nevada issued by the Secretary of State of the State of Nevada as of a date within ten (10) Business Days of the Commencement
Date;

 

(j)       The
Company shall have delivered to the Investor a certified copy of the Articles of Incorporation as certified by the Secretary of
State of the State of Nevada within ten (10) Business Days of the Commencement Date;

 

(k)       The
Company shall have delivered to the Investor a secretary's certificate executed by the Secretary of the Company, dated as of the
Commencement Date, in the form attached hereto as Exhibit B;

 

(l)       The
Registration Statement covering the resale of the Purchase Shares (including, without limitation, all of the Initial Purchase Shares)
and all of the Commitment Shares shall have been declared effective under the Securities Act by the SEC, and no stop order with
respect to the Registration Statement shall be in effect or threatened by the SEC. The Company shall have prepared and filed with
the SEC, not later than one (1) Business Day after the effective date of the Registration Statement, a final and complete prospectus
(the preliminary form of which shall be included in the Registration Statement) and shall have delivered to the Investor a true
and complete copy thereof. Such prospectus shall be current and available for the resale by the Investor of all of the Securities
covered thereby. The Current Report shall have been filed with the SEC, as required pursuant to Section 5(a). All reports,
schedules, registrations, forms, statements, information and other documents required to have been filed by the Company with the
SEC at or during the 12-month period immediately preceding the Commencement Date pursuant to the reporting requirements of the
Exchange Act shall have been filed with the SEC within the applicable time periods prescribed for such filings under the Exchange
Act, including any applicable extension periods contemplated by the Exchange Act;

 

 

 

    	 	25	 

     

    

 

(m)       No
Event of Default (as defined below) has occurred, and no event which, after notice and/or lapse of time, would reasonably be expected
to become an Event of Default has occurred;

 

(n)       All
federal, state and local governmental laws, rules and regulations applicable to the transactions contemplated by the Transaction
Documents and necessary for the execution, delivery and performance of the Transaction Documents and the consummation of the transactions
contemplated thereby in accordance with the terms thereof shall have been complied with, and all consents, authorizations and orders
of, and all filings and registrations with, all federal, state and local courts or governmental agencies and all federal, state
and local regulatory or self-regulatory agencies necessary for the execution, delivery and performance of the Transaction Documents
and the consummation of the transactions contemplated thereby in accordance with the terms thereof shall have been obtained or
made, including, without limitation, in each case those required under the Securities Act, the Exchange Act, applicable state securities
or “Blue Sky” laws or applicable rules and regulations of the Principal Market, or otherwise required by the SEC, the
Principal Market or any state securities regulators;

 

(o)       No
statute, regulation, order, decree, writ, ruling or injunction shall have been enacted, entered, promulgated, threatened or endorsed
by any federal, state or local court or governmental authority of competent jurisdiction which prohibits the consummation of or
which would materially modify or delay any of the transactions contemplated by the Transaction Documents; and

 

(p)       No
action, suit or proceeding before any federal, state, local or foreign arbitrator or any court or governmental authority of competent
jurisdiction shall have been commenced or threatened, and no inquiry or investigation by any federal, state, local or foreign governmental
authority of competent jurisdiction shall have been commenced or threatened, against the Company, or any of the officers, directors
or affiliates of the Company, seeking to restrain, prevent or change the transactions contemplated by the Transaction Documents,
or seeking material damages in connection with such transactions.

 

		9.	INDEMNIFICATION. 

 

In consideration of
the Investor's execution and delivery of the Transaction Documents and acquiring the Securities hereunder and in addition to all
of the Company's other obligations under the Transaction Documents, the Company shall defend, protect, indemnify and hold harmless
the Investor and all of its affiliates, stockholders, members, officers, directors, employees and direct or indirect investors
and any of the foregoing Person's agents or other representatives (including, without limitation, those retained in connection
with the transactions contemplated by this Agreement) (collectively, the "Indemnitees") from and against any and
all actions, causes of action, suits, claims, losses, costs, penalties, fees, liabilities and damages, and expenses in connection
therewith (irrespective of whether any such Indemnitee is a party to the action for which indemnification hereunder is sought),
and including reasonable attorneys' fees and disbursements (the "Indemnified Liabilities"), incurred by any Indemnitee
as a result of, or arising out of, or relating to (a) any misrepresentation or breach of any representation or warranty made by
the Company in the Transaction Documents or any other certificate, instrument or document contemplated hereby or thereby, (b) any
breach of any covenant, agreement or obligation of the Company contained in the Transaction Documents or any other certificate,
instrument or document contemplated hereby or thereby, or (c) any cause of action, suit or claim brought or made against such Indemnitee
and arising out of or resulting from the execution, delivery, performance or enforcement of the Transaction Documents or any other
certificate, instrument or document contemplated hereby or thereby, other than, in the case of clause (c), with respect to Indemnified
Liabilities which directly and primarily result from the fraud, gross negligence or willful misconduct of an Indemnitee. The indemnity
in this Section 9 shall not apply to amounts paid in settlement of any claim if such settlement is effected without the prior written
consent of the Company, which consent shall not be unreasonably withheld, conditioned or delayed. To the extent that the foregoing
undertaking by the Company may be unenforceable for any reason, the Company shall make the maximum contribution to the payment
and satisfaction of each of the Indemnified Liabilities which is permissible under applicable law. Payment under this indemnification
shall be made within thirty (30) days from the date Investor makes written request for it. A certificate containing reasonable
detail as to the amount of such indemnification submitted to the Company by Investor shall be conclusive evidence, absent manifest
error, of the amount due from the Company to Investor. If any action shall be brought against any Indemnitee in respect of which
indemnity may be sought pursuant to this Agreement, such Indemnitee shall promptly notify the Company in writing, and the Company
shall have the right to assume the defense thereof with counsel of its own choosing reasonably acceptable to the Indemnitee. Any
Indemnitee shall have the right to employ separate counsel in any such action and participate in the defense thereof, but the fees
and expenses of such counsel shall be at the expense of such Indemnitee, except to the extent that (i) the employment thereof
has been specifically authorized by the Company in writing, (ii) the Company has failed after a reasonable period of time
to assume such defense and to employ counsel or (iii) in such action there is, in the reasonable opinion of such separate
counsel, a material conflict on any material issue between the position of the Company and the position of such Indemnitee, in
which case the Company shall be responsible for the reasonable fees and expenses of no more than one such separate counsel.

 

 

    	 	26	 

     

    

 

10.       EVENTS
OF DEFAULT. 

 

An "Event of
Default" shall be deemed to have occurred at any time as any of the following events occurs:

 

(a)       the
effectiveness of a registration statement registering the resale of the Securities lapses for any reason (including, without limitation,
the issuance of a stop order or similar order) or such registration statement (or the prospectus forming a part thereof) is unavailable
to the Investor for resale of any or all of the Securities to be issued to the Investor under the Transaction Documents, and such
lapse or unavailability continues for a period of ten (10) consecutive Business Days or for more than an aggregate of thirty (30)
Business Days in any 365-day period, but excluding a lapse or unavailability where (i) the Company terminates a registration statement
after the Investor has confirmed in writing that all of the Securities covered thereby have been resold or (ii) the Company supersedes
one registration statement with another registration statement, including (without limitation) by terminating a prior registration
statement when it is effectively replaced with a new registration statement covering Securities (provided in the case of this clause
(ii) that all of the Securities covered by the superseded (or terminated) registration statement that have not theretofore been
resold are included in the superseding (or new) registration statement);

 

(b)       the
suspension of the Common Stock from trading on the Principal Market for a period of one (1) Business Day, provided that the Company
may not direct the Investor to purchase any shares of Common Stock during any such suspension;

 

(c)       the
delisting of the Common Stock from OTC Markets (or nationally recognized successor to the foregoing), provided, however, that the
Common Stock is not immediately thereafter trading on the New York Stock Exchange, The Nasdaq Capital Market, The Nasdaq Global
Market, The Nasdaq Global Select Market, the NYSE American, the NYSE Arca, or the OTC Bulletin Board (or nationally recognized
successor to any of the foregoing);

 

(d)       the
failure for any reason by the Transfer Agent to issue Purchase Shares to the Investor within two (2) Business Days after the date
on which the Investor is entitled to receive such Purchase Shares under this Agreement;

 

(e)       the
Company breaches any representation, warranty, covenant or other term or condition under any Transaction Document if such breach
would reasonably be expected to have a Material Adverse Effect and except, in the case of a breach of a covenant which is reasonably
curable, only if such breach continues for a period of at least five (5) Business Days;

 

(f)       if
any Person commences a proceeding against the Company pursuant to or within the meaning of any Bankruptcy Law;

 

(g)       if
the Company, pursuant to or within the meaning of any Bankruptcy Law, (i) commences a voluntary case, (ii) consents to the entry
of an order for relief against it in an involuntary case, (iii) consents to the appointment of a Custodian of it or for all or
substantially all of its property, or (iv) makes a general assignment for the benefit of its creditors or is generally unable to
pay its debts as the same become due;

 

(h)       a
court of competent jurisdiction enters an order or decree under any Bankruptcy Law that (i) is for relief against the Company in
an involuntary case, (ii) appoints a Custodian of the Company or for all or substantially all of its property, or (iii) orders
the liquidation of the Company or any Subsidiary;

 

 

 

    	 	27	 

     

    

 

(i)       the
failure of the Company and each of its Subsidiaries to be insured by insurers of recognized financial responsibility against such
losses and risks and in such amounts as reasonably prudent and customary for companies engaged in the businesses in which the Company
and its Subsidiaries are engaged, at a cost that would not materially and adversely affect the condition, financial or otherwise,
or the earnings, business or operations of the Company and its Subsidiaries, taken as a whole; or

 

(i)       if
at any time the Company is not eligible to transfer its Common Stock electronically as DWAC Shares.

 

In addition to any other rights and remedies
under applicable law and this Agreement, so long as an Event of Default has occurred and is continuing, or if any event which,
after notice and/or lapse of time, would reasonably be expected to become an Event of Default, has occurred and is continuing,
the Company shall not deliver to the Investor any Regular Purchase Notice, Accelerated Purchase Notice or Additional Accelerated
Purchase Notice.

 

11.       TERMINATION

 

This Agreement may
be terminated only as follows:

 

(a)       If
pursuant to or within the meaning of any Bankruptcy Law, the Company commences a voluntary case or any Person commences a proceeding
against the Company, a Custodian is appointed for the Company or for all or substantially all of its property, or the Company makes
a general assignment for the benefit of its creditors (any of which would be an Event of Default as described in Sections 10(f),
10(g) and 10(h) hereof), this Agreement shall automatically terminate without any liability or payment to the Company
(except as set forth below) without further action or notice by any Person.

 

(b)       In
the event that (i) the Company fails to file the Registration Statement with the SEC within the period specified in Section
5(a) hereof in accordance with the terms of the Registration Rights Agreement or (ii) the Commencement shall not have occurred
on or before November 30, 2020, due to the failure to satisfy the conditions set forth in Sections 7(II) and 8(II)
above with respect to the Commencement, then, in the case of clause (i) above, this Agreement may be terminated by the Investor
at any time prior to the filing of the Registration Statement and, in the case of clause (ii) above, this Agreement may be terminated
by either party at the close of business on November 30, 2020 or thereafter, in each case without liability of such party to the
other party (except as set forth below); provided, however, that the right to terminate this Agreement under this Section 11(b)
shall not be available to any party if such party is then in breach of any covenant or agreement contained in this Agreement or
any representation or warranty of such party contained in this Agreement fails to be true and correct such that the conditions
set forth in Section 7(II)(c) or Section 8(II)(e), as applicable, could not then be satisfied.

 

(c)       
At any time after the Commencement Date, the Company shall have the option to terminate this Agreement for any reason or for no
reason by delivering notice (a “Company Termination Notice”) to the Investor electing to terminate this Agreement
without any liability whatsoever of any party to any other party under this Agreement (except as set forth below). The Company
Termination Notice shall not be effective until one (1) Business Day after it has been received by the Investor.

 

(d)       This
Agreement shall automatically terminate on the date that the Company sells and the Investor purchases the full Available Amount
as provided herein, without any action or notice on the part of any party and without any liability whatsoever of any party to
any other party under this Agreement (except as set forth below).

 

 

 

    	 	28	 

     

    

 

(e)       If,
for any reason or for no reason, the full Available Amount has not been purchased in accordance with Section 2 of this
Agreement by the Maturity Date, this Agreement shall automatically terminate on the Maturity Date, without any action or notice
on the part of any party and without any liability whatsoever of any party to any other party under this Agreement (except as set
forth below).

 

Except as set forth in Sections 11(a)
(in respect of an Event of Default under Sections 10(f), 10(g) and 10(h)), 11(d) and 11(e), any termination
of this Agreement pursuant to this Section 11 shall be effected by written notice from the Company to the Investor, or the
Investor to the Company, as the case may be, setting forth the basis for the termination hereof. The representations and warranties
and covenants of the Company and the Investor contained in Sections 3, 4, 5, and 6 hereof, the indemnification
provisions set forth in Section 9 hereof and the agreements and covenants set forth in Sections 10, 11 and
12 shall survive the execution and delivery of this Agreement and any termination of this Agreement. No termination of this
Agreement shall (i) affect the Company’s or the Investor’s rights or obligations under (A) this Agreement with respect
to the Initial Purchase or any pending Regular Purchases, Accelerated Purchases or Additional Accelerated Purchases and the Company
and the Investor shall complete their respective obligations with respect to the Initial Purchase and any pending Regular Purchases,
Accelerated Purchases and Additional Accelerated Purchases under this Agreement and (B) the Registration Rights Agreement, which
shall survive any such termination, or (ii) be deemed to release the Company or the Investor from any liability for intentional
misrepresentation or willful breach of any of the Transaction Documents.

 

12.       MISCELLANEOUS.

 

(a)       Governing
Law; Jurisdiction; Jury Trial. The corporate laws of the State of Nevada shall govern all issues concerning the relative rights
of the Company and its stockholders. All other questions concerning the construction, validity, enforcement and interpretation
of this Agreement, the Registration Rights Agreement and the other Transaction Documents shall be governed by the internal laws
of the State of Illinois, without giving effect to any choice of law or conflict of law provision or rule (whether of the State
of Illinois or any other jurisdictions) that would cause the application of the laws of any jurisdictions other than the State
of Illinois. Each party hereby irrevocably submits to the exclusive jurisdiction of the state and federal courts sitting in the
State of Illinois, County of Cook, for the adjudication of any dispute hereunder or under the other Transaction Documents or in
connection herewith or therewith, or with any transaction contemplated hereby or discussed herein, and hereby irrevocably waives,
and agrees not to assert in any suit, action or proceeding, any claim that it is not personally subject to the jurisdiction of
any such court, that such suit, action or proceeding is brought in an inconvenient forum or that the venue of such suit, action
or proceeding is improper. Each party hereby irrevocably waives personal service of process and consents to process being served
in any such suit, action or proceeding by mailing a copy thereof to such party at the address for such notices to it under this
Agreement and agrees that such service shall constitute good and sufficient service of process and notice thereof. Nothing contained
herein shall be deemed to limit in any way any right to serve process in any manner permitted by law. EACH PARTY HEREBY IRREVOCABLY
WAIVES ANY RIGHT IT MAY HAVE, AND AGREES NOT TO REQUEST, A JURY TRIAL FOR THE ADJUDICATION OF ANY DISPUTE HEREUNDER OR IN CONNECTION
HEREWITH OR ARISING OUT OF THIS AGREEMENT OR ANY TRANSACTION CONTEMPLATED HEREBY.

 

(b)       Counterparts.
This Agreement may be executed in two or more identical counterparts, all of which shall be considered one and the same agreement
and shall become effective when counterparts have been signed by each party and delivered to the other party; provided that a facsimile
signature or signature delivered by e-mail in a “.pdf” format data file, including any electronic signature complying
with the U.S. federal ESIGN Act of 2000, e.g., www.docusign.com, www.echosign.adobe.com, etc., shall be considered due execution
and shall be binding upon the signatory thereto with the same force and effect as if the signature were an original signature.

 

 

 

    	 	29	 

     

    

 

(c)       Headings.
The headings of this Agreement are for convenience of reference and shall not form part of, or affect the interpretation of, this
Agreement.

 

(d)       Severability.
If any provision of this Agreement shall be invalid or unenforceable in any jurisdiction, such invalidity or unenforceability shall
not affect the validity or enforceability of the remainder of this Agreement in that jurisdiction or the validity or enforceability
of any provision of this Agreement in any other jurisdiction.

 

(e)       Entire
Agreement. The Transaction Documents supersede all other prior oral or written agreements between the Investor, the Company,
their affiliates and Persons acting on their behalf with respect to the subject matter thereof, and this Agreement, the other Transaction
Documents and the instruments referenced herein contain the entire understanding of the parties with respect to the matters covered
herein and therein and, except as specifically set forth herein or therein, neither the Company nor the Investor makes any representation,
warranty, covenant or undertaking with respect to such matters. The Company acknowledges and agrees that is has not relied on,
in any manner whatsoever, any representations or statements, written or oral, other than as expressly set forth in the Transaction
Documents.

 

(f)       Notices.
Any notices, consents or other communications required or permitted to be given under the terms of this Agreement must be in writing
and will be deemed to have been delivered: (i) upon receipt when delivered personally; (ii) upon receipt when sent by facsimile
or email (provided confirmation of transmission is mechanically or electronically generated and kept on file by the sending party);
or (iii) one Business Day after deposit with a nationally recognized overnight delivery service, in each case properly addressed
to the party to receive the same. The addresses for such communications shall be:

 

If to the Company:

Odyssey Group International, Inc.

2372 Morse Avenue

Irvine, CA 92614

Telephone:(619) 832-2900

E-mail:michael@odysseygi.com

Attention: Michael Redmond,
President and CEO

 

With a copy to (which shall not
constitute notice or service of process):

Troutman Pepper Hamilton Sanders
LLP

400 Berwyn Park

899 Cassatt Road

Berwyn, PA 19312

Telephone:(610) 640-7853

Facsimile:(610) 640-7835

Email:scott.jones@troutman.com

Attention: Scott R. Jones,
Esq.

 

 

 

    	 	30	 

     

    

 

If to the Investor:

Lincoln Park Capital Fund, LLC

440 North Wells, Suite 410

Chicago, IL 60654

Telephone:312-822-9300

Facsimile:312-822-9301

E-mail:jscheinfeld@lpcfunds.com/jcope@lpcfunds.com

Attention:Josh Scheinfeld/Jonathan
Cope

 

With a copy to (which
shall not constitute notice or service of process):

Dorsey &
Whitney LLP

51 West 52nd
Street

New York,
NY 10019

Telephone:(212)
415-9214

Facsimile:
(212) 953-7201

E-mail:marsico.anthony@dorsey.com

Attention:Anthony
J. Marsico, Esq.

 

If to the Transfer Agent:

Empire Stock Transfer

1859 Whitney Mesa Drive

Henderson, Nevada 89014

Telephone: (702) 818-5898

Email: brian@empirestock.com

Attention: Brian Barthlow

 

or at such other address and/or facsimile
number and/or email address and/or to the attention of such other Person as the recipient party has specified by written notice
given to each other party three (3) Business Days prior to the effectiveness of such change. Written confirmation of receipt (A)
given by the recipient of such notice, consent or other communication, (B) mechanically or electronically generated by the sender's
facsimile machine or email account containing the time, date, and recipient facsimile number or email address, as applicable, or
(C) provided by a nationally recognized overnight delivery service, shall be rebuttable evidence of personal service, receipt by
facsimile or email or receipt from a nationally recognized overnight delivery service in accordance with clause (i), (ii) or (iii)
above, respectively.

 

(g)       Successors
and Assigns. This Agreement shall be binding upon and inure to the benefit of the parties and their respective successors and
assigns. The Company shall not assign this Agreement or any rights or obligations hereunder without the prior written consent of
the Investor, including by merger or consolidation. The Investor may not assign its rights or obligations under this Agreement.

 

 

 

    	 	31	 

     

    

 

(h)       No
Third Party Beneficiaries. This Agreement is intended for the benefit of the parties hereto and their respective permitted
successors and assigns and, except as set forth in Section 9, is not for the benefit of, nor may any provision hereof be enforced
by, any other Person.

 

(i)       Publicity.
The Company shall afford the Investor and its counsel with the opportunity to review and comment upon, shall consult with the Investor
and its counsel on the form and substance of, and shall give due consideration to all such comments from the Investor or its counsel
on, any press release, SEC filing or any other public disclosure by or on behalf of the Company relating to the Investor, its purchases
hereunder or any aspect of the Transaction Documents or the transactions contemplated thereby, not less than 24 hours prior to
the issuance, filing or public disclosure thereof. The Investor must be provided with a final version of any portion of such press
release, SEC filing or other public disclosure at least 24 hours prior to any release, filing or use by the Company thereof. The
Company agrees and acknowledges that its failure to fully comply with this provision constitutes a Material Adverse Effect.

 

(j)       Further
Assurances. Each party shall do and perform, or cause to be done and performed, all such further acts and things, and shall
execute and deliver all such other agreements, certificates, instruments and documents, as the other party may reasonably request
in order to consummate and make effective, as soon as reasonably possible, the Commencement, and to carry out the intent and accomplish
the purposes of this Agreement and the consummation of the transactions contemplated hereby.

 

(k)       No
Financial Advisor, Placement Agent, Broker or Finder. The Company represents and warrants to the Investor that, except as set
forth in Schedule 4(v), it has not engaged any financial advisor, placement agent, broker or finder in connection with the
transactions contemplated hereby. The Investor represents and warrants to the Company that it has not engaged any financial advisor,
placement agent, broker or finder in connection with the transactions contemplated hereby. The Company shall be responsible for
the payment of any fees or commissions, if any, of any financial advisor, placement agent, broker or finder relating to or arising
out of the transactions contemplated hereby, including, without limitation, to the Person(s) listed on Schedule 4(v). The Company
shall pay, and hold the Investor harmless against, any liability, loss or expense (including, without limitation, reasonable attorneys'
fees and out of pocket expenses) arising in connection with any such claim.

 

(l)       No
Strict Construction. The language used in this Agreement will be deemed to be the language chosen by the parties to express
their mutual intent, and no rules of strict construction will be applied against any party.

 

(m)       Remedies,
Other Obligations, Breaches and Injunctive Relief. The Investor’s remedies provided in this Agreement, including, without
limitation, the Investor’s remedies provided in Section 9, shall be cumulative and in addition to all other remedies available
to the Investor under this Agreement, at law or in equity (including a decree of specific performance and/or other injunctive relief),
no remedy of the Investor contained herein shall be deemed a waiver of compliance with the provisions giving rise to such remedy
and nothing herein shall limit the Investor's right to pursue actual damages for any failure by the Company to comply with the
terms of this Agreement. The Company acknowledges that a breach by it of its obligations hereunder will cause irreparable harm
to the Investor and that the remedy at law for any such breach may be inadequate. The Company therefore agrees that, in the event
of any such breach or threatened breach, the Investor shall be entitled, in addition to all other available remedies, to an injunction
restraining any breach, without the necessity of showing economic loss and without any bond or other security being required.

 

 

 

    	 	32	 

     

    

 

(n)       Enforcement
Costs. If: (i) this Agreement is placed by the Investor in the hands of an attorney for enforcement or is enforced by the Investor
through any legal proceeding; (ii) an attorney is retained to represent the Investor in any bankruptcy, reorganization, receivership
or other proceedings affecting creditors' rights and involving a claim under this Agreement; or (iii) an attorney is retained to
represent the Investor in any other proceedings whatsoever in connection with this Agreement, then the Company shall pay to the
Investor, as incurred by the Investor, all reasonable costs and expenses including reasonable attorneys' fees incurred in connection
therewith, in addition to all other amounts due hereunder.

 

(o)       Amendment
and Waiver; Failure or Indulgence Not Waiver. No provision of this Agreement may be amended or waived by the parties from and
after the date that is one (1) Business Day immediately preceding the initial filing of the Registration Statement with the SEC.
Subject to the immediately preceding sentence, (i) no provision of this Agreement may be amended other than by a written instrument
signed by both parties hereto and (ii) no provision of this Agreement may be waived other than in a written instrument signed by
the party against whom enforcement of such waiver is sought. No failure or delay in the exercise of any power, right or privilege
hereunder shall operate as a waiver thereof, nor shall any single or partial exercise of any such power, right or privilege preclude
other or further exercise thereof or of any other right, power or privilege.

 

 

 

* * * * *

 

 

 

 

 

 

 

    	 	33	 

     

    

 

IN WITNESS WHEREOF, the Investor
and the Company have caused this Agreement to be duly executed as of the date first written above.

 

 

 

 

THE COMPANY:

 

ODYSSEY GROUP INTERNATIONAL,
INC.

 

 

By: /s/ J. Michael Redmond                             

Name: Joseph Michael Redmond

Title:
President and CEO

 

 

 

 

INVESTOR:

 

LINCOLN PARK CAPITAL FUND,
LLC

BY: LINCOLN PARK CAPITAL, LLC

BY: ROCKLEDGE
CAPITAL CORPORATION

 

 

By: /s/ Josh Scheinfeld                             

Name: Josh Scheinfeld

Title: President

 

 

 

 

 

    	 	34	 

     

    

 

EXHIBITS

 

 

	Exhibit A	Form of Officer’s Certificate
	Exhibit B	Form of Resolutions of Board of Directors of the Company
	Exhibit C	Form of Secretary’s Certificate
	Exhibit D	Form of Letter to Transfer Agent
	 	 

 

 

 

 

 

 

 

 

 

 

 

 

    	 	35	 

     

    

 

EXHIBIT A

 

FORM OF OFFICER’S CERTIFICATE

 

This Officer’s
Certificate (“Certificate”) is being delivered pursuant to [Section 8(I)(c)] [Section 8(II)(e)] of that
certain Purchase Agreement dated as of August 13, 2020, (“Purchase Agreement”), by and between ODYSSEY GROUP
INTERNATIONAL, INC., a Nevada corporation (the “Company”), and LINCOLN PARK CAPITAL FUND, LLC (the
“Investor”). Terms used herein and not otherwise defined shall have the meanings ascribed to them in the Purchase
Agreement.

 

The undersigned, [________________],
[______________________] of the Company, hereby certifies, on behalf of the Company and not in his individual capacity, as follows:

 

1.       I
am the [_______________________] of the Company and make the statements contained in this Certificate;

 

2.       The
representations and warranties of the Company are true and correct in all material respects (except to the extent that any of such
representations and warranties is already qualified as to materiality in Section 4 of the Purchase Agreement, in which case, such
representations and warranties are true and correct without further qualification) as of the date when made and as of [the date
hereof] [the Commencement Date] as though made at that time (except for representations and warranties that speak as of a specific
date, in which case such representations and warranties are true and correct as of such date);

 

3.       The
Company has performed, satisfied and complied in all material respects with covenants, agreements and conditions required by the
Transaction Documents to be performed, satisfied or complied with by the Company at or prior to the [the date hereof] [the Commencement
Date].

 

4.       The Company has not taken any steps, and does not currently expect to take any steps, to seek protection pursuant
to any Bankruptcy Law nor does the Company or any of its Subsidiaries have any knowledge or reason to believe that its creditors
intend to initiate involuntary bankruptcy or insolvency proceedings. The Company is financially solvent and is generally able
to pay its debts as they become due.

 

IN WITNESS WHEREOF,
I have hereunder signed my name on this ___ day of ___________.

 

______________________

Name:

Title:

 

The undersigned as
Secretary of ODYSSEY GROUP INTERNATIONAL, INC., a Nevada corporation, hereby certifies that [______________] is the duly
elected, appointed, qualified and acting [______________] of ODYSSEY GROUP INTERNATIONAL, INC. and that the signature appearing
above is his genuine signature.

 

___________________________________

[_____________], Secretary

 

 

    	 	36	 

     

    

 

EXHIBIT B

 

FORM OF COMPANY RESOLUTIONS

FOR SIGNING PURCHASE AGREEMENT

 

UNANIMOUS WRITTEN CONSENT OF

ODYSSEY GROUP INTERNATIONAL, INC.

 

The undersigned, constituting
all of the members of the Board of Directors (the “Board”) of Odyssey Group International, Inc., a Nevada corporation
(the “Corporation”), pursuant to Section 78.315(2) of the Nevada Revised Statutes and in accordance with the
bylaws of the Company, hereby approve and adopt the following recitals and resolutions by written consent effective as of later
date as all signatures are affixed to this written consent:

 

WHEREAS, there
has been presented to the Board of Directors of the Corporation a draft of the Purchase Agreement (the “Purchase Agreement”),
by and between the Corporation and Lincoln Park Capital Fund, LLC (“Lincoln Park”), providing for the purchase
by Lincoln Park of up to Ten Million Two Hundred Fifty Thousand Dollars ($10,250,000) of the Corporation’s common stock,
$0.001 par value per share (the “Common Stock”); and

 

WHEREAS, after
careful consideration of the Purchase Agreement, the documents incident thereto and other factors deemed relevant by the Board
of Directors, the Board of Directors has determined that it is advisable and in the best interests of the Corporation to engage
in the transactions contemplated by the Purchase Agreement, including, but not limited to, (i) the issuance of 793,802 shares of
Common Stock to Lincoln Park as a commitment fee upon the execution of the Purchase Agreement (the “Commitment Shares”),
(ii) the sale of 602,422 shares of Common Stock (collectively, the “Initial Purchase Shares”) upon execution
of the Purchase Agreement for aggregate consideration of $250,000 and (iii) the sale of up to $10,000,000 worth of additional shares
of Common Stock to Lincoln Park under the Purchase Agreement from time to time thereafter (the "Purchase Shares").

 

Transaction Documents

 

NOW, THEREFORE,
BE IT RESOLVED, that the transactions described in the Purchase Agreement are hereby approved, including the sale by the Corporation
of up to $10,250,000 of shares of Common Stock pursuant to the terms thereof, and that _______________________ (the “Authorized
Officers”) be, and each of them hereby is, authorized to execute and deliver the Purchase Agreement, and any other agreements
or documents contemplated thereby including, without limitation, a registration rights agreement (the “Registration Rights
Agreement”) providing for the registration of the shares of the Company’s Common Stock issuable in respect of the
Purchase Agreement on behalf of the Corporation, with such amendments, changes, additions and deletions as the Authorized Officers
may deem to be appropriate and approve on behalf of, the Corporation, such approval to be conclusively evidenced by the signature
of an Authorized Officer thereon; and

 

 

 

    	 	37	 

     

    

 

FURTHER RESOLVED,
that the terms and provisions of the Registration Rights Agreement by and among the Corporation and Lincoln Park (a copy of which
has been circulated to the Board) are hereby approved and that the Authorized Officers be, and each of them hereby is, authorized
to execute and deliver the Registration Rights Agreement (pursuant to the terms of the Purchase Agreement), with such amendments,
changes, additions and deletions as the Authorized Officer may deem appropriate and approve on behalf of, the Corporation, such
approval to be conclusively evidenced by the signature of an Authorized Officer thereon; and

 

FURTHER RESOLVED,
that the terms and provisions of the forms of Irrevocable Transfer Agent Instructions and Notice of Effectiveness of Registration
Statement, copies of which have been circulated to the Board (collectively, the “Instructions”), are hereby
approved and that the Authorized Officers be, and each of them hereby is, authorized to execute and deliver the Instructions on
behalf of the Company in accordance with the Purchase Agreement, with such amendments, changes, additions and deletions as the
Authorized Officers may deem appropriate and approve on behalf of, the Corporation, such approval to be conclusively evidenced
by the signature of an Authorized Officer thereon; and

 

Issuance of Common Stock

 

FURTHER RESOLVED,
that the Corporation is hereby authorized to issue to Lincoln Park Capital Fund, LLC, 793,802 shares of Common Stock as Commitment
Shares and that upon issuance of the Commitment Shares pursuant to the Purchase Agreement the Commitment Shares shall be duly authorized,
validly issued, fully paid and nonassessable with no personal liability attaching to the ownership thereof; and

 

FURTHER RESOLVED,
that the Corporation is hereby authorized to issue to Lincoln Park Capital Fund, LLC, 602,422 shares of Common Stock as Initial
Purchase Shares and that upon issuance of the Initial Purchase Shares pursuant to the Purchase Agreement the Initial Purchase Shares
shall be duly authorized, validly issued, fully paid and nonassessable with no personal liability attaching to the ownership thereof;
and

 

FURTHER RESOLVED,
that the Corporation is hereby authorized to issue shares of Common Stock upon the purchase of Purchase Shares (including Initial
Purchase Shares) up to the Available Amount under the Purchase Agreement in accordance with the terms of the Purchase Agreement
and that, upon issuance of the Purchase Shares pursuant to the Purchase Agreement, the Purchase Shares will be duly authorized,
validly issued, fully paid and nonassessable with no personal liability attaching to the ownership thereof; and

 

FURTHER RESOLVED,
that the Corporation shall initially reserve 20,000,000 shares of Common Stock for issuance as Purchase Shares (other than Initial
Purchase Shares) under the Purchase Agreement.

 

 

 

    	 	38	 

     

    

 

Filing of 8-K

 

RESOLVED, that
the Authorized Officers be, and each of them hereby is, authorized and directed to prepare, verify, sign and file, or cause to
be prepared, verified, signed and filed, in the name and on behalf of the Company, such current reports on Form 8-K and other filings
under the Securities Exchange Act of 1934, as amended, as the Authorized Officer acting shall deem necessary or appropriate or
as may be required by applicable law, and each such Authorized Officer or such other person as any such Authorized Officer shall
designate in writing is authorized to execute and deliver, in the name and on behalf of the Corporation, any and all agreements,
undertakings, instruments and other documents and to do any and all things which may be necessary or appropriate in connection
therewith.

 

Registration Statement

 

RESOLVED, that
the Authorized Officers be, and each of them acting alone hereby is, authorized, empowered and directed, for and on behalf of the
Corporation, to cause to be prepared, to execute and to cause to be filed with the Securities and Exchange Commission (the “Commission”),
in accordance with the Securities Act and in conformity with the rules and regulations thereunder, one or more registration statements
on Form S-1 (each, a “Registration Statement” and collectively, the “Registration Statements”)
or any other form as may be necessary or appropriate to enable the resale of the Common Stock issued pursuant to the Offering in
such form and containing such terms and provisions as may be approved by the Authorized Officers, with such changes therein, or
additions, amendments or supplements thereto as such officer or officers executing the same shall approve, his, her or their execution
thereof to be conclusive evidence of such approval.

 

RESOLVED FURTHER,
that the Authorized Officers be, and each of them acting alone hereby is, authorized to prepare, execute and file with the Commission,
on behalf of the Corporation, any amendments to any Registration Statement and/or any supplements to the prospectus relating to
the shares of Common Stock in the Offering as they may in their discretion deem necessary or advisable.

 

RESOLVED FURTHER,
that the execution of any such Registration Statement by the Authorized Officers, as required by the rules and regulations of the
Commission, is hereby authorized and approved.

 

RESOLVED FURTHER,
that the Authorized Officers be, and each of them acting alone hereby is, authorized from time to time to do, or cause to be done,
all such other acts and things and to execute and deliver all such instruments and documents, as each such Authorized Officer shall
deem necessary or appropriate to cause any Registration Statement to be filed with the Commission and declared effective consistent
with the intent of the foregoing resolutions.

 

 

 

    	 	39	 

     

    

 

Blue Sky

 

RESOLVED,
that the Authorized Officers be, and each of them acting alone hereby is, authorized, empowered and directed, for and on behalf
of the Corporation, to take any and all actions which they deem necessary or advisable in order to effect the registration or qualification
(or exemption therefrom) of shares of Common Stock in the Offering under the blue sky or securities laws of any of the states or
jurisdictions of the United States and in connection therewith to execute, acknowledge, verify, deliver, file or cause to be filed
any notices, filings, consents to service of process, appointments of attorneys to receive service of process and other papers
and instruments which may be required under such laws, and to take any and all further action which they deem necessary or advisable
in order to maintain any such registration or qualification for as long as they deem necessary or as required by law.

 

RESOLVED FURTHER,
that each resolution required to be adopted in each such state in order to affect such registration or qualification or to obtain
such an exemption therefrom is hereby adopted, and the Authorized Officers are, and each of them acting alone hereby is, directed
to attach a copy of each resolution so adopted pursuant to this Unanimous Written Consent.

 

Approval of Actions

 

FURTHER RESOLVED,
that, without limiting the foregoing, the Authorized Officers are, and each of them hereby is, authorized and directed to proceed
on behalf of the Corporation and to take all such steps as deemed necessary or appropriate, with the advice and assistance of counsel,
to cause the Corporation to consummate the agreements referred to herein and to perform its obligations under such agreements;
and

 

FURTHER RESOLVED,
that the Authorized Officers be, and each of them hereby is, authorized, empowered and directed on behalf of and in the name of
the Corporation, to take or cause to be taken all such further actions and to execute and deliver or cause to be executed and delivered
all such further agreements, amendments, documents, certificates, reports, schedules, applications, notices, letters and undertakings
and to incur and pay all such fees and expenses as in their judgment shall be necessary, proper or desirable to carry into effect
the purpose and intent of any and all of the foregoing resolutions, and that all actions heretofore taken by any officer or director
of the Corporation in connection with the transactions contemplated by the agreements described herein are hereby approved, ratified
and confirmed in all respects.

 

(Signature Page Follows)

 

 

 

    	 	40	 

     

    

 

IN WITNESS WHEREOF,
the undersigned, being all of the members of the Board of Directors of the Company, do hereby execute this Unanimous Written Consent
on the date set forth below each such undersigned’s name. This Unanimous Written Consent may be executed in counterparts,
with each an original and all of which together shall constitute one and the same instrument. A signature or signatures delivered
by facsimile or other electronic transmission, or an electronic transmission indicating approval of this Unanimous Written Consent,
shall be deemed to be an original signature or signatures or approval and shall be valid and binding to the same extent as if it
was an original.

 

DIRECTORS

 

	 	 	 	 
	Name:	 	Name:	 
	 	 	 	 
	 	 	 	 
	Name:	 	Name:	 
	 	 	 	 
	 	 	 	 
	Name:	 	Name:	 
	 	 	 	 
	 	 	 	 

________________________

Name:  
 

 

 

being all of the directors of ODYSSEY GROUP INTERNATIONAL,
INC.

 

 

 

 

 

    	 	41	 

     

    

 

EXHIBIT C

 

FORM OF SECRETARY’S
CERTIFICATE

 

This Secretary’s
Certificate (“Certificate”) is being delivered pursuant to Section 8(II)(k) of that certain Purchase Agreement
dated as of August 13, 2020 (“Purchase Agreement”), by and between ODYSSEY GROUP INTERNATIONAL, INC., a Nevada
corporation (the “Company”) and LINCOLN PARK CAPITAL FUND, LLC (the “Investor”), pursuant to which
the Company may sell to the Investor up to Ten Million Two Hundred Fifty Thousand Dollars ($10,250,000) of the Company's Common
Stock, $0.001 par value per share (the "Common Stock"). Terms used herein and not otherwise defined shall have the meanings
ascribed to them in the Purchase Agreement.

 

The undersigned, [________________], Secretary
of the Company, hereby certifies, on behalf of the Company and not in his individual capacity, as follows:

 

1.       I
am the Secretary of the Company and make the statements contained in this Secretary’s Certificate.

 

2.       Attached
hereto as Exhibit A and Exhibit B are true, correct and complete copies of the Company’s bylaws (“Bylaws”)
and Articles of Incorporation (“Charter”), in each case, as amended through the date hereof, and no action has been
taken by the Company, its directors, officers or stockholders, in contemplation of the filing of any further amendment relating
to or affecting the Bylaws or Charter.

 

3.       Attached
hereto as Exhibit C are true, correct and complete copies of the resolutions duly adopted by the Board of Directors of the
Company on [___________], 2020, at which a quorum was present and acting throughout. Such resolutions have not been amended, modified
or rescinded and remain in full force and effect and such resolutions are the only resolutions adopted by the Company’s Board
of Directors, or any committee thereof, or the stockholders of the Company relating to or affecting (i) the entering into and performance
of the Purchase Agreement, or the issuance, offering and sale of the Purchase Shares and the Commitment Shares and (ii) and the
performance of the Company of its obligation under the Transaction Documents as contemplated therein.

 

4.       As
of the date hereof, the authorized, issued and reserved capital stock of the Company is as set forth on Exhibit D hereto.

 

 

 

 

 

    	 	42	 

     

    

 

IN WITNESS WHEREOF,
I have hereunder signed my name on this ____ day of ________, 2020.

 

_________________________

Name:

Secretary

 

 

The undersigned as
Chief Financial Officer of ODYSSEY GROUP INTERNATIONAL, INC., a Nevada corporation, hereby certifies that [____________________]
is the duly elected, appointed, qualified and acting Secretary of ODYSSEY GROUP INTERNATIONAL, INC., and that the signature
appearing above is his genuine signature.

 

___________________________________

Name:

Chief Financial Officer

 

 

 

 

    	 	43	 

     

    

 

EXHIBIT D

 

FORM OF LETTER TO THE TRANSFER AGENT
FOR THE ISSUANCE OF THE INITIAL PURCHASE SHARES AND THE COMMITMENT SHARES AT SIGNING OF THE PURCHASE AGREEMENT

 

 

 

[COMPANY LETTERHEAD]

 

 

 

August [_], 2020

 

Empire Stock Transfer

1859 Whitney Mesa Drive

Henderson, Nevada 89014

Attention: Brian Barthlow

 

Re: Issuance of Common Stock to Lincoln Park Capital Fund, LLC

 

Dear Mr. Barthlow:

 

On behalf of ODYSSEY GROUP INTERNATIONAL,
INC. (the “Company”), you are hereby instructed to issue as soon as possible a book-entry statement
representing an aggregate of 1,396,224 shares of our common stock in the name of Lincoln Park Capital Fund, LLC.
The book-entry statement should be dated [_____________], 2020. I have included a true and correct copy of resolutions duly adopted
by the Company’s Board of Directors approving the issuance of these shares. The book-entry statement should bear the following
restrictive legend:

 

THE SECURITIES REPRESENTED HEREBY
HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR APPLICABLE STATE SECURITIES LAWS. THE SECURITIES HAVE
BEEN ACQUIRED FOR INVESTMENT AND MAY NOT BE OFFERED FOR SALE, SOLD, TRANSFERRED OR ASSIGNED IN THE ABSENCE OF AN EFFECTIVE REGISTRATION
STATEMENT FOR THE SECURITIES UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR APPLICABLE STATE SECURITIES LAWS, UNLESS SOLD PURSUANT
TO: (1) RULE 144 UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR (2) AN OPINION OF HOLDER’S COUNSEL, IN A CUSTOMARY FORM,
THAT REGISTRATION IS NOT REQUIRED UNDER SAID ACT OR APPLICABLE STATE SECURITIES LAWS.

 

The book-entry statement should be sent as soon as possible
via overnight mail to the following address:

 

Lincoln Park Capital Fund, LLC

440 North Wells Street, Suite 410

Chicago, IL 60654

Attention: Josh Scheinfeld/Jonathan
Cope

 

Thank you very much for your help. Please call me at [__________]
if you have any questions or need anything further.

 

ODYSSEY GROUP INTERNATIONAL, INC.

 

 

By:_____________________________

Name:

Title:

 

 

 

 

    	 	44

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00313-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00313-of-00352.parquet"}]]